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ABSTRACT

Intense interest has focused on the development of enzymes as next-generation catalysts
for the production of molecules with biotechnological potential. OleT JE, a member of the
cytochrome P450 CYP152 family is an excellent candidate for the generation of advanced
biofuels. OleTJE catalyzes the hydrogen peroxide-dependent decarboxylation of C n fatty
acids to produce Cn-1 terminal alkenes. Despite the ability of this enzyme to yield long chain
alkenes with nearly exclusive chemoselectivity, its reactivity towards shorter chain length
substrates results in undesired levels of hydroxylated side-products, limiting its industrial
potential. Previous transient kinetic studies have demonstrated that, despite its unusual
chemistry, the reaction is initiated by canonical substrate hydrogen-atom abstraction by an
iron(IV)-oxo intermediate (compound I) followed by the formation of a hyperstable
iron(IV)-hydroxide species (compound II). The origin of chemoselectivity in OleTJE, and
CYP152s in general, has been probed by a coordinated study of several CYP152 family
members, including OleTJE, P450-BSβ, CYP-MP, and the newly characterized OleT SA.
Spectroscopically labeled substrates, in concert with UV-Vis spectroscopy, EPR
spectroscopy and transient kinetic studies show that substrate constriction is necessary for
alkene production, but compromises the rate of product egress. Moreover, alteration of the
environment surrounding the axial thiolate ligand in OleT SA via mutagenesis has allowed
the establishment of a platform to extend research towards the electronic characterization
of the catalytically relevant intermediates, compound I and compound II.
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CHAPTER 1
MIXED REGIOSPECIFICITY COMPROMISES ALKENE SYNTHESIS
BY A CYTOCHROME P450 PEROXYGENASE FROM
METHYLOBACTERIUM POPULIǂ
Abstract
Intensive interest has focused on enzymes that are capable of synthesizing
hydrocarbons, alkenes and alkanes, for sustainable fuel production. A recently described
cytochrome P450 (OleT-JE) from the CYP152 family catalyzes an unusual carbon-carbon
scission reaction, transforming C n fatty acids to C n-1 1-alkenes. Here, we show that a second
CYP152, CYP-MP from Methylobacterium populi ATCC BAA 705, also catalyzes
oxidative substrate decarboxylation. Alkene production is accompanied with the
production of fatty alcohol products, underscoring the mechanistic similarity of the
decarboxylation reaction with canonical P450 monooxygenation chemistry. The
branchpoint of these two chemistries, and regiospecificity of oxidation products, is strongly
chain length dependent, suggesting an importance of substrate coordination for regulating
alkene production.

ǂ

Amaya, J. A.; Rutland, C. D.; Makris, T. M., Mixed regiospecificity compromises alkene
synthesis by a cytochrome P450 peroxygenase from Methylobacterium populi. J Inorg
Biochem 2016, 158, 11-6.
Reprinted here with permission of publisher.
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1. Introduction
Widespread biotechnological interest has focused on the identification

1-4

and

reconstitution of enzymes capable of synthesizing gaseous 5-6 or liquid hydrocarbon fuels
in microbial hosts

5, 7-9

. A recently discovered cytochrome P450 isolated from

Jeotgalicoccus sp. ATCC 8456, termed OleT-JE

2

(or CYP152L1)

10

, catalyzes the

hydrogen peroxide dependent cleavage of Cn fatty acids for the synthesis of C n-1 alkenes
and a carbon dioxide co-product 11. The OleT-JE reaction converts a biologically abundant
feedstock into a hydrocarbon (and useful commodity chemical for organic synthesis) in a
one-step reaction that consumes an inexpensive co-substrate. Given its tremendous
potential for advanced biofuel production, a number of recent efforts have focused on the
optimization of OleT-JE catalysis. These include the development of alternative photo- 12
and bio- 13-14 catalytic turnover methods to maximize alkene production in vitro, thereby
potentially bypassing the requirement for H2O2, which may prove to be more difficult to
leverage in a microbial platform.
The oxidative decarboxylation reaction catalyzed by OleT-JE is highly atypical,
although not unprecedented 15-16, for P450s, which typically catalyze the monooxygenation
of substrates (reviewed in 17-18). Primary sequence analysis places OleT-JE as a member of
the CYP152 family, which includes the fatty acid hydroxylases P450 SP 19-22, P450 BS
23

and P450 CLA 24. The structure of OleT-JE, solved by the Munro and Leys groups, has

confirmed a high degree of structural similarity of the OleT-JE active-site

10

with BS23

and SP25, including direct interaction of the fatty acid carboxylate necessary for the
efficient utilization of H2O2 with an active site arginine (Arg245 in OleT-JE). A large
steady-state substrate 2H kinetic isotope effect (KIE)
2

26

for SPand BS hydroxylations

indicates that the peroxygenase reaction proceeds by substrate C-H bond abstraction by a
high-valent iron(IV)-oxo  cation radical Compound I intermediate

27

. Ensuing oxygen

rebound 28-29 results in a distribution of  and  mono-hydroxylated products.
In recent work by our laboratory 11, we evaluated the mechanism of the OleT-JE
alkene forming reaction with an eicosanoic (C20) fatty acid substrate, a chain length which
is presumed to approximate the native substrate of OleT-JE based on identification of 18methyl-nonadecene as the predominant alkene found in Jeotgalicoccus 2. Substrate and
H2O2 labeling studies confirmed that alkene formation is accompanied with the formation
of a carbon dioxide co-product that derives from the fatty acid terminal carboxylate.
Significantly, no oxygen insertion was observed in the CO 2 co-product, hinting at a clear
mechanistic deviation of alkene forming and P450 monooxygenation chemistries. Further
evaluation of the OleT-JE reaction by single-turnover stopped flow kinetics, however,
strongly links the two mechanisms 11. Rapid mixing of per-deuterated C20 fatty acid bound
with H2O2 resulted in the direct observation of a catalytically competent Compound I
species 27, 30-31 on route to alkene formation. These species did not significantly accumulate
in parallel reactions with protiated substrate, suggesting that alkene formation also
proceeds by substrate hydrogen atom abstraction. Taken together, the mechanisms for P450
aliphatic hydroxylations, and the initial steps for OleT-JE oxidative decarboxylation,
provides evidence for branching following an initial C-H bond abstraction event, as
depicted in Figure 1.1. This scheme is additionally supported by altered product profiles
observed for OleT-JE in reactions with shorter fatty acid substrates. Although OleT-JE
predominantly generates 1-nonadecene in single 11 and multiple turnover 2, 13 reactions with

3

eicosanoic acid (C20), the metabolism of shorter chain length substrates often results in an
increased production of hydroxylated fatty acid side products 13, 32.

Figure 1.1 Proposed mechanistic branching for fatty acid hydroxylation and
decarboxylation catalyzed by OleT-JE11

Important questions remain regarding the relative importance of electronic and
active-site structural contributions on the hydroxylation/decarboxylation branchpoint in
OleT-JE, which would potentially aid in leveraging its catalysis further. This has prompted
us to reexamine the efficiency of alkene production by CYP152 orthologs. While OleT-JE
is the founding member for P450 fatty acid decarboxylases, work by Rude et al.2 previously
demonstrated that other CYP152 enzymes may also have the capacity to produce alkenes
2

. Among a series of CYP152 enzymes tested towards palmitic acid (C 16) decarboxylation

in that study, a P450 from Methylobacterium populi ATCC BAA 705 (accession number
ZP_02200540), which we denote hereafter as CYP-MP, was found to produce

4

pentadecene. The reported high chemoselectivity of CYP-MP towards palmitic acid
decarboxylation, and low sequence identity of CYP-MP to OleT-JE (31%), including
significant differences in active-site, made it an attractive system to begin to evaluate
structural contributions on alkene formation. Here, we have cloned, overexpressed, and
characterized CYP-MP reactivity towards a panel of fatty acid chain length substrates.
Analytical experiments provide evidence for low alkene yields, and a large distribution of
hydroxylation products that surprisingly extends beyond the fatty acid C position. Product
yield, efficiency of alkene formation, and the regioselectivity of products show significant
chain length dependence. We have additionally examined the proposed role of an activesite histidine in OleT-JE, thought to be important for alkene production, through its
introduction into CYP-MP.

2. Experimental procedures
2.1 Reagents
Ni-NTA and Butyl Sepharose resins were obtained from Qiagen and GE Healthcare
respectively. An E. coli codon optimized gene of Mpop_1292, the orf encoding CYP-MP
from Methylobacterium populi (ATCC BAA-705) was synthesized by DNA 2.0 (Menlo
Park, CA). The original construct contained a C-terminal TEV cleavage site followed by a
His6 tag. Fatty acids and N,O-Bis (trimethylsilyl) trifluoroacetamide (BSTFA) were
purchased from the Supelco Analytical branch of Sigma Aldrich. Hydrogen peroxide was
obtained from Sigma Aldrich. The pDB-HisGST and pMHTDelta238 (expressing tobacco

5

etch virus (TEV) protease 33) plasmids were obtained from the DNASU plasmid repository.
Expression and purification of TEV followed described protocols. 33
2.2 Subcloning, heterologous expression and purification of Mpop_1292
The original CYP-MP expression plasmid was digested using NdeI and XhoI, excising the
Mp_1292 gene, and ligated into a similarly digested pDB-HisGST. Cloning was verified
by sequencing at ACGT Inc. Heterologous expression was performed in E. coli BL21
(DE3) cells using modified Terrific broth (consisting of 12 g yeast extract, 6 g tryptone and
1 g bactopeptone, 125 mg thiamine, trace metals and 50 mg kanamycin per liter of culture).
Cells were grown at 37 °C at 220 rpm, and the temperature was reduced to 20 °C at OD600
~ 0.4 and supplemented with 10 mg/L delta aminolevulinic acid. At an OD600 ~ 1, cultures
were induced with 0.1 mM IPTG. Cells were harvested after 24 hours, centrifuged and
stored at -80 oC. Preliminary expression trials indicated that the P450 was exclusively
localized in the membrane fraction. As a result, the pellet was resuspended in lysis buffer
containing detergent (50 mM potassium phosphate (KPi) pH 8, 10 mM imidazole, and 0.1
M NaCl, containing 0.8% w/v cholate, 1 mM PMSF and 15 % (v/v) glycerol) (buffer A),
and stirred for 2 hours at 4 oC. Cells were disrupted using a Branson sonifier and allowed
to stir for an additional hour. Following centrifugation for 45 minutes at 17,000 g, the
supernatant was loaded onto a Ni-NTA column, washed with 10 column volumes of buffer
A containing 30 mM imidazole, and eluted with buffer A with 250 mM imidazole.
Cleavage of the N-terminal GST tag was performed by addition of 1 mg of TEV protease
per 25 mg of P450 and proteolysis was allowed to proceed for 16 hours at 4 °C. Ammonium
sulfate was subsequently added to 25 % saturation and the protein was loaded onto a butyl
sepharose column equilibrated in 50 mM KPi pH 8, 0.1 M NaCl, 25 % ammonium sulfate,
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and 15 % glycerol (buffer B). The column was washed with 5 column volumes of buffer B
and eluted with 50 mM KPi pH 8, 0.4 % cholate and 15 % glycerol. SDS-PAGE confirmed
that the GST leader had been completely removed and that the protein was highly
homogeneous. The final yield of purified P450 was roughly 40 mg per liter of culture.
2.3 Spectroscopy
Optical spectroscopy was performed on an Agilent 8453 spectrophotometer. An extinction
coefficient of CYP-MP ( = 104 mM-1 cm-1 at 422 nm) was determined using the pyridine
hemochromagen method 34. The ferrous carbonmonoxy P450 adducts were prepared by the
addition of carbon monoxide gas to a solution of ferric P450, and subsequent reduction of
the protein with sodium dithionite. EPR spectra were recorded using an X-band Bruker
EMXplus spectrometer equipped with an Oxford Instruments ESR900 liquid helium
continuous flow cryostat. Spectra were recorded at a temperature of 20 K, a 1 mT
modulation amplitude, and 1 mW microwave power. The concentration of protein was 200
µM.
2.4 Site Directed Mutagenesis
Site directed mutagenesis of the Met96His CYP-MP variant was performed using the
following primer and its reverse complement:
5’ GATCATGGTTCTGTGCATGTTCTGGATGGTGCC 3’
Mutation was confirmed by gene sequencing at EtonBio Inc.

7

2.5 Optimizing turnover yields in OleT-JE
OleT-JE was expressed, purified, and adventitiously bound E. coli derived fatty acids were
removed as described 11. The effect of the rate of hydrogen peroxide addition on turnover
efficiency was analyzed by mixing 2 mL of 5 mM hydrogen peroxide to a 2 mL reaction
containing 200 mM KPi pH 7.5, 5 µM OleT-JE and 500 µM eicosanoic acid (prepared as
a 10 mM stock solution in DMSO). H2O2 was added either by fast addition or by calibrated
delivery over the course of 30, 60 or 120 minutes using a New Era NE-1000 syringe pump.
The reactions were quenched with 6 M HCl after 2 total hours (including addition time)
and products were analyzed on gas chromatography as described in more detail below.
2.6 CYP-MP Activity Assays
Hydrogen peroxide (2 mL, 5 mM) was slowly added over the course of one hour to a 2 mL
reaction containing 200 mM KPi pH 7.5, 5 µM CYP-MP and 500 µM fatty acid (prepared
as a 10 mM stock in DMSO) using a New Era NE-1000 syringe pump. Products were
extracted by adding an equal volume of chloroform to the resulting reaction mixture. In
order to account for differential response factors of alkenes, fatty acids and OH-fatty acids
for accurate product quantitation, two internal standards (500 nmoles of each) were added
upon reaction completion. These consisted of 1-hexadecene throughout and a fatty acid
two carbons shorter than the substrate. Following extraction, the organic phase was
derivatized by adding 250 molar equivalents of BSTFA (to initial substrate concentration)
and incubated for 20 minutes at 60 °C. The derivatization mixture was dried using a stream
of N2 and re-dissolved in 100 µL CHCl3. For gas chromatography (GC), 3 µL was analyzed
on an Hewlett-Packard 5890 gas chromatograph using an HP-5 column with the following
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oven conditions: 170 °C for 3 minutes, a 10 °C/min to 220 °C, a 5 °C/min to 320 °C, and
320 °C for 3 minutes. The response factors between fatty acids, hydroxy fatty acids and
alkenes were determined by analyzing known authentic fatty acids (C20-C10), 2hydroxyhexadecanoic acid and 1-hexadecene standards.
2.7 GC Mass-Spectrometry (GC-MS)
Gas chromatography mass spectrometry (GC-MS) was performed at the University of
South Carolina Mass Spectrometry facility with a Hewlett Packard HP5890 GC and a 30meter Rbx-5 column. Mass spectra were recorded on a Waters VG 705 magnetic sector
mass spectrometer using 70 eV electron impact energy.

3. Results
3.1 Heterologous expression and membrane localization of CYP-MP
A C-terminal hexahistidine tagged CYP-MP synthetic gene, with a T5 promoter,
showed poor expression in E. coli BL21(DE3), which did not improve upon alteration with
a T7 promoter. In order to maximize expression, a TEV cleavable Glutathione-STransferase (GST) solubility tag was introduced at the N-terminus of CYP-MP by subcloning into the pDB-HisGST vector. Expression trials indicated a high level of protein
production, and that the fusion was contained in the membrane fraction. In order to confirm
subcellular localization, a membrane fraction was prepared by isolating spheroplasts,
which were shown to contain at least 90 % of CYP-MP (Figure 1.2).

9

Figure 1.2 SDS PAGE showing the membrane localization of GST tagged CYP-MP.
Molecular weight markers in kDa shown to the left (lane 1); soluble fraction after lysozyme
treatment (lane 2); spheroplasts (lane 3); soluble fraction after sonication of spheroplasts
(lane 4); insoluble fraction after sodium cholate treatment (lane 5); soluble fraction after
sodium cholate treatment.

Treatment of spheroplasts with detergent (0.8 % sodium cholate) led to efficient
solubilization of the fusion protein, which could be subsequently purified by affinity
chromatography in the presence of detergent. The GST tag was cleaved as described in
Methods, and CYP-MP was purified from the GST fragment using hydrophobic interaction
chromatography (Figure 1.3). Native, untagged CYP-MP, which has a high predicted pI
(~9.6), was found to require the presence of detergent in order to remain in a soluble, nonaggregated form. This feature suggests that the membrane localization of the full-length
construct is likely not attributable to the presence of the N-terminal GST, but is rather a
general feature of CYP-MP.

10

Figure 1.3 SDS PAGE showing TEV cleavage and purification of CYP-MP. Molecular
weight markers in kDa shown to the left (lane 1); GST/CYP-MP as purified from affinity
Ni-NTA (lane 2); GST/CYP-MP after TEV cleavage (lane 3); purified CYP-MP after
hydrophobic interaction chromatography (lane 4).

3.2 Spectroscopic characterization of CYP-MP
The optical spectrum of untagged, cholate solubilized CYP-MP at pH 8.0 is shown
in Figure 1.4A and the inset. The purified ferric form of CYP-MP (solid line) has a
perturbed red shifted Soret maximum at 422 nm, versus 417 nm that is typical for low-spin
(LS) water bound P450s, a prominent  band at 545 nm and a significantly weaker  band
at 575 nm. Significant hyper-porphyrin characteristics 35 are also visible at ~360 nm. These
spectroscopic features are indicative of an altered coordination environment in CYP-MP,
possibly deriving from binding of an alternative axial ligand
proximal thiolate to the inactive neutral thiol form
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36 37

, or protonation of the

. The latter possibility is ruled out

through examination of the optical spectrum of the ferrous carbonmonoxy-bound form of
CYP-MP (Figure 1.4A, dashed line), which displays the characteristic spectrum (max ~
448 nm) for thiolate ligated Fe2+-CO complexes. Only minor contributions (<15 %) from

11

the catalytically inactive ‘P420’ form is observed. Addition of excess fatty acid (C12 to C18
chain lengths) to the ferric enzyme resulted in no detectable optical spectroscopic changes
(Figure 1.4B), such as the low to high spin-state conversion that is readily observed in
OleT-JE and other P450s upon substrate binding 10-11.

Figure 1.4 UV/Vis absorption spectra of CYP-MP in ferric (solid and inset) and ferrous
carbonmonoxy-bound (dashed) forms (A). UV-Vis absorption spectra of as isolated CYPMP, and upon addition of 80 µM fatty acids of varying chain-lengths.

The active-site structure of CYP-MP was further probed by X-band electron paramagnetic
resonance (EPR) spectroscopy (Figure 1.5). The EPR spectrum of the isolated enzyme
(Figure 1.5, top trace) is comprised of one major form with g-values at 2.49, 2.26, and 1.87.
The gz = 2.49 for CYP-MP is higher than those typically observed for ferric water-ligated
P450s, that usually fall in the range of gz ≤ 2.45 39-40. Similarly large gz values have been
previously observed for P450s with nitrogen or anionic oxygen donors bound trans to the
cysteine thiolate

36, 40

. As there is no amino acid in the modeled active-site of CYP-MP

(Figure 1.14) that could readily provide such a ligand to the heme iron, we assign these
12

spectroscopic features as most likely deriving from a ferric-hydroxide bound form of the
enzyme. No high spin signals are observed upon the addition of any chain length fatty acid
to the enzyme, in agreement with optical spectroscopic data. However, the addition of 4
molar equivalents of stearic (C18) acid to the enzyme results in the conversion of a fraction
of the enzyme to a new low-spin ferric form with g values of 2.52, 2.26, and 1.87. This
new species could in principle derive either from subtle changes in hydroxide ligand
geometry, or from direct coordination of the fatty acid carboxylate to the heme. However,
this latter scenario would seem unlikely based on the lack of significant optical
spectroscopic changes upon fatty acid addition to CYP-MP (Figure 1.4B), and known
structures of fatty acid bound CYP152 enzymes 10, 23, 25, in which the fatty acid carboxylate
forms a salt bridge with a conserved active site arginine (retained as Arg256 in CYP-MP).
Accordingly, the addition of shorter chain length substrates (ex. C 16) which are readily
metabolized by CYP-MP fail to reproduce the g = 2.52 signal that is specifically observed
upon stearic acid binding.

Figure 1.5 X-band EPR of CYP-MP as purified (top trace) and upon the addition of 4
molar equivalents of C18 and C16 chain length fatty acids (middle and lower traces,
respectively)
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3.2 Characterization of CYP-MP Reaction Products
Previous multiple turnover studies of OleT-JE have shown that the addition of excess
hydrogen peroxide results in low conversion of substrate

32

. The addition of excess

peroxide to CYP-MP in the presence of fatty acids resulted in similarly poor product yields
(<10%) despite long incubation times, suggesting possible inactivation of the enzyme. We
explored whether a slow addition of H2O2 would circumvent these issues in OleT-JE, and
by extension CYP-MP, enabling both higher turnover numbers and more accurate product
quantitation.

Figure 1.6 Effect of varying the peroxide addition time on the efficiency of OleT-JE
metabolism of eicosanoic acid to nonadecene. Final concentrations after mixing are 2.5
µM OleT-JE, 250 µM fatty acid and 2.5 mM hydrogen peroxide.
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Assays were performed with OleT-JE and eicosanoic acid, in which a fixed amount of
oxidant (ten-fold molar excess to fatty acid), was added at varying rates, maintaining a total
incubation time of 2 hours. Figure 1.6 demonstrates the effect of this slow H2O2 perfusion
technique on OleT-JE turnover yields. Nonadecene yields are maximized, and approach
completion when H2O2 is added over a 60-minute period. Nonadecene is the only product
detected under these turnover conditions (Figure 1.7), in accordance with single turnover
studies reported earlier by our group 11.

Figure 1.7 Representative GC chromatogram for the reaction of OleT-JE, H2O2 and C20
fatty acid. No appreciable signal at a retention time corresponding for β-hydroxy C20 fatty
acid (RT = 25.7 min) is observed (inset).
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Similar turnover methods were tested with CYP-MP and a panel of fatty acid chain length
substrates. Following extraction, samples were derivatized by silylation with BSTFA to
enable the detection of non-metabolized substrate (mono-), and hydroxylated (di-silylated)
fatty acids, together with 1-alkene. Two internal standards, consisting of a fatty acid of
similar chain length as the substrate (C n-2) and hexadecane, were included to ensure
accurate quantitation of all product forms. The response factors of each were determined
through analysis of authentic alkene, fatty acid, and -OH fatty acid standards.
Representative chromatograms for the metabolism of each substrate are included in
Supplementary information (Figures 1.8 to 1.10) and the results are summarized in Table
1. Unlike OleT-JE, CYP-MP poorly metabolizes eicosanoic acid, and only  hydroxylated
products were detected.

Figure 1.8 Representative GC chromatogram for the reaction of CYP-MP, H2O2, and C20
(A) or C18 (B) fatty acid substrates
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Figure 1.9 Representative GC chromatogram for the reaction of CYP-MP, H2O2 and C16
(A) or C14 (B) fatty acid substrates

Figure 1.10 Representative GC chromatogram for the reaction of CYP-MP, H2 O2 and a
C12 fatty acid substrate
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Table 1.1: Fatty acid metabolism and product distribution of WT and M96H CYP-MP
Cytochrome
P450

WT CYP-MP

Substrate

Conversion
(%)

Product distributions (%)
1-alkene

 -OH

 -OH

, ,  OH

8.4 ±
5.8
3.4 ±
0.1
3.4 ±
0.4
7.9 ±
0.7

48.3 ±
6.7
65.4 ±
1.1
69.3 ±
2.6
71.0 ±
5.5

5.0 ± 0.8

C20

< 1% a

C18

18.4 ± 1.2

C16

64.0 ± 4.8

C14

88. 9 ± 2.7

38.3 ±
4.7
23.9 ±
0.9
n.d.

C12

99.9 ± 0.1

n.d.

7.3 ± 0.2
27.3 ± 2.8
21.1 ± 6.2

< 1% b
Met96His
C12, 14, 16
a
only -hydroxylated fatty acid products were detected
b

mostly -alcohol fatty acids

n.d. not detected

The conversion yields considerably improve with a decrease in substrate chain length, and
result in nearly stoichiometric products formed from reactions of CYP-MP and lauric acid
(C12). Detectable, albeit low, levels of alkene are observed in reactions of C 18 and C16
substrates. As previously reported for OleT-JE

13, 32

, decarboxylation chemoselectivity

decreases with a reduction in carbon number, and is completely abolished in reactions of
C14 and C12 substrates with CYP-MP.
Although hydroxylation at the C position forms the major product across the C20
to C12 series, the turnover of short chain fatty acids, particularly C 16 and below, results in
the appearance of large distribution of products in respective chromatograms (Figure 1.9
and 1.10). The retention times of these peaks, shortly following  and  di-silylated
hydroxylated fatty acid products, suggested that they may correspond to hydroxylated
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derivatives that extended beyond the C position. In order to unambiguously identify these
putative oxidation products, GC-MS was performed. Representative mass fragmentation
patterns of hydroxylated products that derive from reactions with C 16 and C14 substrates
are presented in Figure 1.11 and Figure 1.12 respectively.

Figure 1.11 GC/MS fragmentation patterns of derivatized (di-silylated) hydroxy-fatty acid
products in reactions of CYP-MP, C16 fatty acid, and H2O2 showing α (A), β (B), γ (C) and
δ (D) forms. The mass of major fragment ions is indicated with respective assignments in
the inset

The mass fragmentation patterns of the products that result from reactions of CYP-MP with
C16 and C14 clearly show that  and OH-fatty acids are formed. In the case of C14 and C12,
these products extend as far as the position, suggesting a number of substrate binding
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modes afforded by the CYP-MP active site. To our knowledge, these distal oxidation
products have not been observed in reactions of other CYP152 enzymes, which have only
been shown to form  and  fatty alcohols.

Figure 1.12 Representative GC chromatogram for the reaction of CYP-MP, H2 O2 and
C12 fatty acid substrate

Given the relatively poor alkene formation by CYP-MP relative to OleT-JE, we tested
whether an active-site mutation may be able to rescue its activity. A noted difference from
a pairwise structural comparison of OleT-JE, BSβ, and SPα is the presence of an activesite histidine in OleT-JE (His85) that is replaced by a glutamine in BSβ and SPα. In OleTJE, the His85 Nε2 group is positioned ~ 5.9 Å from the heme iron and could possibly serve
a role to promote the decarboxylation pathway through hydrogen bonding interaction, or
20

possible proton donation, to an incipient iron(IV)-hydroxide formed as a result of C-H bond
abstraction. This residue is replaced by a methionine (Met96) in CYP-MP, which is
incapable of forming such a hydrogen bond. The Met96His mutant was generated,
characterized by optical spectroscopy, and has similar general optical features as the wildtype enzyme in the ferric state, including a similar Soret maximum, prominent β band, and
a second absorption band at 360 nm (Figure 1.13). Reduction with dithionite in the
presence of CO reveals that the enzyme is partially (~40 %) in the inactive P420 form,
observed in multiple preparations of the enzyme. The results of turnover studies with C12,
C14, and C16 substrates (Table 1) show that introduction of an active-site histidine does not
restore alkene production. The CYP-MP Met96His mutant displays poor metabolism of
fatty acids, resulting in less than <1 % conversion. The meager levels of product that are
detectable only comprise hydroxylated fatty acid products.

Figure 1.13 UV-Vis absorption spectra of the CYP-MP Met96His mutant in ferric (solid)
and ferrous carbon-monoxy forms
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4. Discussion
It is shown here that CYP-MP is capable of producing alkenes, extending the
unusual OleT-JE oxidative decarboxylation reaction to a second CYP152. The observation
of alcohol products, in addition to alkenes, is consistent with previous proposals that very
similar chemical mechanisms give rise to both products. 11

Production of an alkene

necessitates the loss of a hydrogen from the C position. Therefore, it would seem logical
that the decarboxylation reaction is initiated by C-H bond abstraction by Compound I at
this position. Unfortunately, the perdeuterated fatty acid probe utilized in our previous
transient kinetics studies of OleT-JE does not allow for precise targeting of this abstraction
to a C-H. In light of this, it is notable that C alcohols are the predominant CYP-MP
reaction product in reactions of all chain length (CL) substrates. C-H bond abstraction at
C is not the sole requirement for efficient decarboxylation. Additional structural or
electronic factors are likely required to inhibit an oxygen rebound step following the
formation of Compound II.
The native substrate for CYP-MP is not currently known. Given the high abundance
of mono-unsaturated (largely C18) fatty acids found in many Methylobacteria

41

, it is

possible that the native substrate of CYP-MP may not be among those tested in this study.
Nonetheless, the spectroscopic and activity assays reported here begin to provide a more
detailed framework for understanding the active site requirements for alkene formation.
The capacity of CYP-MP to catalyze decarboxylation demonstrates that an active-site
histidine is not an obligate requirement for substrate carbon-carbon scission. Nonetheless,
CYP-MP is much less productive than OleT-JE for the synthesis of alkenes from longer
(C18 and C20) substrates. The strict chain length dependence of CYP-MP decarboxylase
22

activity also alludes to an importance of substrate identity in controlling the
monooxygenation/decarboxylation branchpoint. For comparison, there is some ambiguity
regarding the CL dependence of OleT-JE, which may result from variations in reaction
conditions, the oxidant utilized (O2/electrons versus H2O2), and analytical methods
employed 13-14, 32. Although reported yields vary significantly in these studies, OleT-JE has
been shown to produce increasing amounts of  and  OH-fatty acids, and consequently
less alkene, upon CL reduction from C20 to C16. An associated decreased capacity for
shorter chain fatty acids to induce a low- to high-spin state conversion in OleT-JE 10 may
signal the presence of multiple substrate coordination modes within the active-site, leading
to an increased accessibility of the heme iron to water. These relationships have been
extensively studied in other P450s, including CYP101 mutants and substrate analogs (ex.
42-45

). While optical spin-state transitions are not directly observable for CYP-MP upon the

binding of substrates, it is notable that perturbation of the ferric-hydroxide EPR spectrum
is only observed upon binding of a substrate (C18) that shows the largest efficiency for
alkene formation. Likewise, the product distributions for shorter chain fatty acids,
extending as far as the C position for C12, clearly demonstrate that shorter CL substrates
adopt a variety of conformations within the CYP-MP active site. As for OleT-JE, decreased
regiospecificity compromises the efficiency of the alkene forming pathway in CYP-MP.
In order to identify the possible structural factors that may give rise to a large
distribution of CYP-MP oxidation products, a homology model (based on the C20 fatty acid
bound X-ray structure of OleT-JE, PDB 4L40 10) was generated using the I-TASSER server
46

. An overlay of the two active sites is shown in Figure 1.14. Assuming that fatty acids

bind in a similar orientation to CYP-MP as OleT-JE, smaller hydrophilic side chains
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replace the phenylalanine residues found in OleT-JE (Phe79 and 172) that lie in close
contact with the substrate. Without the anchoring of these residues in CYP-MP, the fatty
acid may be able to shift more readily, allowing for a greater propensity for target C-H
bond abstraction and incipient oxygen rebound. Controlling substrate binding modes, in
this case, may serve as a guide for understanding the differential alkene-producing ability
of different CYP152 enzymes. They may also serve as a template for improving the
efficiency of OleT-JE with alternative substrates.

Figure 1.14 Overlay of the predicted active-site structure of CYP-MP (pink) and
eicosanoic acid (C20) bound OleT-JE (purple) PDB: 4L40
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CHAPTER 2
A DISTAL LOOP CONTROLS PRODUCT RELEASE, CHEMO- AND
REGIO-SELECTIVITY IN CYTOCHROME P450 DECARBOXYLASES
Abstract
The cytochrome P450 OleT-JE utilizes hydrogen peroxide (H2O2) to catalyze the
decarboxylation or hydroxylation of fatty acid (FA) substrates. Both reactions are initiated
through the abstraction of a substrate hydrogen atom by the high-valent iron-oxo
intermediate known as Compound I. Here, we specifically probe the influence of substrate
coordination on OleT-JE reaction partitioning through the combined use of fluorescent and
EPR-active FAs, and mutagenesis of structurally disordered F-G loop that is far removed
from the heme-iron active-site. The labeled probes are efficiently metabolized and reveal
a slow product release step, mediated by the F-G loop, that limits OleT-JE turnover. A
single amino acid change or truncation of the loop reveals that this region establishes
critical interactions to anchor FA substrates in place and allow for regiospecific C-H
abstraction and decarboxylation to occur.

Amaya, J. A.; Rutland, C. D.; Leschinsky, N.; Makris, T. M., A Distal Loop Controls
Product Release and Chemo- and Regioselectivity in Cytochrome P450 Decarboxylases.
Biochemistry 2018, 57 (3), 344-353
Reprint with permission from publisher.
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1. Introduction
High-valent iron-oxo species have been directly implicated in a plethora of
important biosynthetic transformations. In addition to more common monooxygenase
reactions that result from the integration of one atom of atmospheric dioxygen into
substrates, recent studies have established the intermediacy of iron-oxo intermediates for
catalyzing substrate halogenations,1 epimerizations,2 dehydrogenations,3 and heterocyclic
ring formation4 in non-heme iron enzymes. Following the abstraction of a scissile substrate
C-H bond, these enzymes have evolved complex mechanisms that can change the nature
of the ensuing rebound reaction by altering both the efficiency and sometimes the identity
of the activated radical species. The analogous iron(IV)-oxo unit in heme enzymes,
commonly referred to as Compound I, has a substantially more rigid structure from
invariable ligands provided by the porphyrin cofactor and axial ligand, and would thus
appear to offer less catalytic flexibility.

Nonetheless, heme-containing enzymes,

particularly cytochrome P450s (CYPs), have been implicated in diverse set of chemistries
that can include oxidative desaturations 5 and decarboxylations, 6-7 among others.
Until very recently, the highly reactive 8 nature of CYP Compound I intermediate
has prohibited its direct visualization in a reaction other than the archetypal
monooxygenation. This has limited understanding the origins for heme-enzyme reaction
diversification. The CYP OleT-JE, named for its olefin-forming capacity, catalyzes the
decarboxylation of fatty acid substrates using H 2O2 as a co-substrate.7

The substrate-

assisted mechanism that allows for the efficient activation of peroxide in OleT-JE, and is
very likely common to other CYP152 orthologs, has enabled isolation of Compound I (OleI) 9 in the OleT-JE C-C cleavage reaction and revealed a significant substrate 2H kinetic
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isotope effect (KIE) for Ole-I decay. This, and subsequent observation of the OleT-JE
Compound II intermediate (Ole-II)

10

has demonstrated that oxygen insertion and

decarboxylation both proceed from the same substrate hydrogen atom transfer step
(Scheme 2.1).
A number of studies have sought to clarify the important regulatory elements
required to sufficiently hamper oxygen rebound in OleT-JE and route the enzyme towards
further oxidation of the substrate in order to allow decarboxylation to occur. Inspiration
has largely derived from comparison of the OleT-JE structure with CYP152 orthologs with
variable abilities to navigate the decarboxylation/hydroxylation branchpoint, in particular,
the archetypal CYP152 hydroxylase BS.11 As a result, mutagenesis experiments have
targeted active site residues and the immediate microenvironment that differ between the
two enzymes.7, 12-13 Although this line of inquiry, augmented by theory, 14-15 has identified
possible roles for proton donation pathways and solvent in mediating the switch, growing
evidence has suggested that additional elements may be required to reinforce
decarboxylation.
Several lines of evidence have alluded to a sophisticated interplay of substrate
binding modes and mobility, mediated by the protein scaffold, for controlling the fate of
activated oxygen species in OleT-JE. Primarily, OleT-JE exhibits mixed chemoselectivity
7, 12-13, 16-17

and hydroxylates some non-native chain length substrates with variable

proficiency through a canonical rebound mechanism. 18

This mixed functionality is

reiterated in CYP-MP, another CYP152 ortholog that is devoid of an active site histidine
(H85 in OleT-JE) that has been highlighted as a principle difference between BS and
OleT-JE.

19

Introduction of the activating substrate-acid required for efficient H2O2
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utilization by active site mutation

20

or via a substrate misrecognition strategy

18

allows

OleT-JE to insert oxygen into an even broader range of hydrocarbons. The radical
recombination efficiencies measured from radical clock studies using the latter approach
are indistinguishable from those measured for CYP monooxygenases. 18
Here, we have adopted a new strategy to examine OleT-JE reaction partitioning
that preserves the active site features of OleT-JE, but introduces variations to the fatty acid
(FA) substrate at positions of the protein that are far removed from the heme-iron active
site. Using fatty acid substrates with spectroscopically-active probes appended to different
points along the acyl chain, we have identified a slow product release step that limits OleTJE turnover. These probes indicate that a structurally disordered region of OleT-JE known

Scheme 2.1 Proposed mechanism for the atypical decarboxylation (green) and canonical
hydroxylation (purple) reactions catalyzed by the cytochrome P450 OleT-JE. Following
the binding of the fatty acid substrate and activation of H 2O2, both reactions are initiated
via hydrogen atom transfer (HAT) to OleT-JE compound I (Ole-I) to form Ole-II. The
reaction then bifurcates, depending on the nature of the substrate. Either an electron from
the substrate is abstracted that is coupled to proton transfer, resulting in decarboxylation to
an alkene, or oxygen rebound occurs, forming a fatty alcohol.
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as the F-G loop is critical for mediating product release. This same region is critical for
anchoring the FA substrate. Disruption of the interactions of the F-G loop and substrate,
with as little as a single amino acid change, converts OleT-JE from a decarboxylase into a
monooxygenase, even though the active site structure has been left completely preserved.

2. Experimental Procedures

2.1 Reagents and chemicals
All buffers used in this study were purchased from BDH Chemicals. Peptone,
tryptone, yeast extract and thiamine were purchased from Research Products International
(Mt. Prospect, IL, USA). Antibiotics were purchased from BioBasic Inc (Markham, ON
Canada).
obtained

Hydrogen peroxide and 11-(dansylamino)undecanoic acid (DAUDA) were
from

Sigma

Aldrich.

Protiated

fatty

acids,

N,O-

Bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) (99:1)
were purchased from Supelco (Bellefonte, PA, USA). 16-doxylstearic acid was purchased
from Santa Cruz Biotechnology (Dallas, TX, USA). 11-aminoundecanoic acid was
obtained from Acros Organics (Morris, NJ, USA). Dansyl chloride and alkene standards
were purchased from TCI Chemicals (Portland, OR, USA). The pChuA expression vector
was obtained from Addgene (plasmid #42539) and was a kind gift from Alan Jasanoff. 21

2.2 Fluorescent fatty acid synthesis
The dansylated fatty acid derivative 11-(dansylamino)-undecanoic acid (DAUDA)
was synthesized by dissolving 11-aminoundecanoic acid (2 mmol) in 90 mL of H 2O with
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sodium bicarbonate (20 mmol). To this suspension, 24 mL of a 1:6 solution of
triethylamine:acetone (vol:vol) containing dansyl chloride (1 mmol) was added dropwise
over the course of one hour while stirring at room temperature. The reaction was then
acidified with 0.5 M HCl to pH 2 and extracted with three times 75 mL of ethyl acetate.
The organic phase was completely evaporated under a stream of N 2. The resulting white
solid was resuspended in 50 mL EtOH and stored at -20 °C. The concentration of DAUDA
was determined by optical spectroscopy using an extinction coefficient (ε335 nm = 4800 M-1
cm-1). Final yields were typically 80 – 90 %.

2.3 OleT-JE mutagenesis
OleT-JE L176G: Site-directed mutagenesis employed standard molecular biology
procedures and partially overlapping primers. The following primers were utilized with
the newly-introduced codon underlined:
5’GTGCGGGCGGTGGTGCGTGGAAGGGCTATAAGGCG 3’
5’ CCACCGCCCGCACGAAAGCTATCGATCATGATGTCCATATCG 3’.
OleT-JE Δ3aa: The deletion mutant to truncate the F-G loop was generated using
restriction-free cloning with the following megaprimer and its reverse complement:
5’TAGCTTTCGTGCGCTGGGTGGTAAGGGCTATAAGGCGAAAGAGGCGCGTCG
TCGTGTTG 3’.
All mutations were verified by sequencing at EtonBio Inc (Durham, NC, USA).
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2.4 Heterologous expression and purification of OleT-JE
The expression and purification of wild-type OleT-JE, L176G, and the Δ3aa
mutant, were identical.

The OleT-JE-containing plasmid was co-transformed into

BL21(DE3) with the hemin importer ChuA and the pG-TF2 plasmid (Takara Bio) that
encodes for GroEL, GroES and Tig chaperones. One colony was inoculated in 100 mL of
modified Terrific Broth (24 g of yeast extract, 12 g of tryptone and 1 g of bactopeptone per
liter) that was supplemented with 100 µg/mL ampicillin, 20 µg/mL chloramphenicol and
50 µg/mL kanamycin and grown overnight at 37 °C. The following day, 10 mL of starter
culture was used to inoculate 500 mL cultures of Terrific Broth supplemented with 100
µg/mL ampicillin, 20 µg/mL chloramphenicol, 50 µg/mL kanamycin, 125 mg/L thiamine
and trace metals. Cultures were grown at 37 °C until OD600nm = 0.6 was reached, and the
temperature was reduced to 18 °C and grown for an additional hour until the OD600nm
reached ~ 1.5. Cells were then induced with 10 ng/mL tetracycline, 50 µM IPTG and 5
mg/L hemin and grown overnight at 18 °C. The following day, cells were harvested by
centrifugation at 6000 g for 10 minutes and the pellet was frozen at -80 °C until further
use. Cells were resuspended in 4 mL of Buffer A (50 mM K2HPO4 pH 8, 300 mM NaCl
and 10 mM imidazole) per gram of pellet. Cells were disrupted using a Branson sonifier
and stirred for an hour before centrifuging 30 minutes at 16,000 rpm. The supernatant was
loaded onto a previously equilibrated nickel-nitriloacetic acid (Ni-NTA) column, washed
with buffer A + 25 mM imidazole and eluted with buffer A + 250 mM imidazole. The
eluate was diluted 1:1 (vol:vol) with Buffer B (50 mM K2HPO4 pH 8, 300 mM NaCl, 60
% ammonium sulfate) to reach a final concentration of 30 % ammonium sulfate. The
protein was then loaded onto a Butyl-S-Sepharose column equilibrated in buffer C (50 mM
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K2HPO4 pH 8, 300 mM NaCl, 30 % ammonium sulfate), washed with 10 column volumes
of the same buffer and subsequently eluted with a linear gradient to 50 mM K2 HPO4 pH 8
over 8 column volumes. Fractions with an absorbance ratio (A418nm/A280nm) higher than 0.9
were pooled and dialyzed against 200 mM K2HPO4 pH 7.5. The protein was concentrated,
flash frozen in liquid nitrogen and stored at -80 oC.

2.5 UV-Visible Spectroscopy
Optical spectra were obtained using an HP 8453 spectrophotometer. Fatty acid
titrations were performed using 6 - 10 µM OleT-JE in 200 mM K2HPO4 pH 7.5 and the
sequential addition of substrate from a 10 mM stock solution. Unlabeled fatty acid
substrates (C20 through C12) were dissolved in a 70:30 (v:v) mix of ethanol and Triton X100. The labeled 16-doxylstearic acid and DAUDA fatty acids were dissolved in DMSO
and ethanol respectively. The amount of solvent added never exceeded 5 % of the total
volume of the solution during the course of the titration. The substrate-induced absorption
changes at 417 nm were plotted as a function of total substrate concentration. The high
affinity of these substrates warrants fitting to a Morrison quadratic expression

22

in order

to determine a dissociation constant (KD). We 9, 18-19 and others 13, 23 have described these
fitting procedures in previous substrate-binding studies of OleT-JE.

2.6 Fluorescence binding experiments
Fluorescence spectroscopy was performed on a Cary Varian Eclipse fluorimeter
with conditions identical to the UV-Vis titrations. In experiments that probed the local
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environment of DAUDA, an excitation wavelength of 340 nm was used. In studies used
to selectively probe OleT-JE-bound DAUDA for binding studies, a Forster Resonance
Energy Transfer (FRET) approach was used. The fluorescence from tryptophans of OleTJE (λexcitation = 280 nm, λemission ~ 340 nm) was used to excite bound DAUDA (λ emission =
500 - 550 nm).

The fluorescence intensity at 500 nm was plotted as a function of the

concentration of DAUDA and fit in a similar fashion to the UV/Vis titration data.

2.7 Steady-state turnover
Steady-state activity assays were performed as previously described.24 OleT-JE
(10 nmol) was mixed with substrate (1 μmol) in 200 mM K2HPO4 pH 7.5 in a total volume
of 2 mL. 1000 µmol of H2O2 (also in 2 mL of 200 mM K2HPO4 pH 7.5) was slowly added
over the course of one hour using a syringe pump after which the reaction was immediately
quenched with 100 µL of 12 M HCl. For samples analyzed by gas chromatography (GC),
unlabeled fatty acids and the 16-DSA probe, internal standards (alkene and fatty acid) were
subsequently added and the reaction was extracted with an equal volume of chloroform.
The organic phase was concentrated and derivatized with 250 molar equivalents of
BSTFA:TMCS (99:1). Samples were incubated at 60 °C for 30 minutes and analyzed by
Gas Chromatography-Mass Spectrometry (GC-MS).

GC-MS was performed at the

University of South Carolina Mass Spectrometry facility with a Hewlett-Packard HP5890
Gas Chromatograph and an Agilent HP-5 column. The following oven conditions were
used to detect the products from C20 through C16 fatty acid metabolism: 170 °C for 3 min,
a 10 °C/min linear gradient to 220 °C, a 5 °C/min to 320 °C, and 320 °C for 3 min. The
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following oven conditions were used to detect the products obtained from C14 and C12 fatty
acid metabolism: 100 °C for 3 min, a 5 °C/min gradient to 250 °C and a 250 °C for 3 min.
Analysis of DAUDA metabolites was done by LC/MS using a Dionics 3000RS and a
Chromegabond WR C18 column using absorbance detection at 340 nm. The identity of
hydroxylated and alkene products was determined by LC-MS using a Waters QTOF
APIUS.

2.8 Stopped-flow transient kinetics
2.8.1 Enzyme Preparation
All P450s were initially peroxide-treated with 15 molar equivalents of H2O2 and
desalted into 200 mM K2HPO4 pH 7.5 on a PD-10 desalting column (GE Healthcare) to
remove adventitiously bound fatty acids. The protein was then concentrated to ~ 200 µM
and diluted in 200 mM K2HPO4 pH 7.5 to a final concentration of 20 µM. Three molar
equivalents of fatty acid were subsequently added from a 10 mM stock and incubated at 4
°C for at least 4 hours to ensure complete fatty acid binding. A stock of 10 mM H2O2 was
prepared in K2HPO4 pH 7.5 and incubated at 4 °C for 4 hours.
2.8.2 Data collection and kinetic analysis
Stopped-flow experiments were carried out on an Applied Photophysics Ltd. SX20
stopped-flow spectrophotometer. Briefly, each protein stock was rapidly mixed 1:1 with
H2O2 in 200 mM KPi pH 7.5.

Single wavelength traces were collected using a

photomultiplier tube (PMT) and full spectral data was acquired using photodiode array
(PDA) detection. OleT-JE Compound I (Ole-I) and Compound II (Ole-II) decay rates were
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obtained by fitting the PMT time courses at 370 nm or 440 nm. The data can be analyzed
in ProData software using the following two-summed exponential expression:
𝐴𝑡,𝑜𝑏𝑠 = 𝐴∞ + 𝑎1𝑒 −𝑡/𝑡1 + 𝑎2 𝑒 −𝑡/𝑡2

(Eq. 1)

At,obs is the observed absorbance, 1/t is the reciprocal relaxation time (RRT) of a particular
phase (in s-1), a is the amplitude of that phase, t is time (s) and 𝐴∞ is the final absorbance.
The RRTs can be evaluated using the following kinetic model where Fe 3+(HS) and
Fe3+(LS) are the high-spin and low-spin forms of the enzyme. Ole-I and Ole-II have their
usual designations:
𝑘1
𝑘2
𝑘3
Fe (HS) + H2 O2 ⇄ Ole − I → Ole − II → Fe3+ (LS)
𝑘−1
3+

(Eq. 2)

Both Ole-I and Ole-II have significant absorption contributions at both 370 and 440 nm
wavelengths. However, the RRTs can be assigned based on their amplitudes and apparent
rates. The fast phase with larger amplitude (RRT1) can be ascribed to Ole-I decay (also
Ole-II formation) where the slower, smaller amplitude phase (RRT 2) represents Ole-II
decay. The two steps can also be delineated on the basis of the dependence on H 2O2
concentration. In reactions with protiated fatty acids, such as the DAUDA and 16-DSA
employed in this study, we have empirically determined that the RRT1 versus [H2O2] plots
yield a linear concentration dependence while RRT2 is H2O2 independent due to the
irreversibility of the C-H bond cleavage in the preceding step. The linear dependence of
RRT1 arises from a rate-limiting H2O2 binding step. As a result, the apparent KD for H2O2
binding can be determined by dividing the intercept (k -1) by the slope (k1) of the RRT1
versus H2O2 plot.
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2.8.3 Transient fluorescence
Stopped-flow fluorescence studies were performed using the FRET approach described
above. The prepared OleT-JE:DAUDA complex was mixed with H2O2 and data was
collected using a fluorescence PMT equipped with a 510 nm bandpass filter. The
fluorescence data could be fit to a two-summed expression with RRTs that are significantly
slower than those measured for Ole-I and Ole-II decay and are independent of H2O2. The
slower RRT with a positive amplitude corresponds to a decrease in fluorescence (i.e. loss
of FRET between OleT-JE and the metabolized DAUDA) and gives the rate of product
release from the enzyme.

2.9 Spin-probe EPR spectroscopy
2.9.1 Sample preparation
OleT-JE (wild-type or variants) was desalted in 200 mM K2HPO4 pH 7.5 and
diluted to a final concentration of 100 µM. One molar equivalent of 16-doxylstearic acid
(16-DSA) from a 26 mM stock prepared in DMSO was added (final DMSO concentration
never exceeded 5%). After incubating for 1 hour at 4 °C to ensure complete binding, 0 30 molar equivalents of hydrogen peroxide were added. The final OleT-JE and 16-DSA
concentrations were 75 µM. The reaction was allowed to incubate for one hour prior to
data collection. The samples, approximately 40 μL each, were loaded into glass capillaries
and EPR was recorded at room temperature (298 K) using an X-band Bruker EMXplus
spectrometer with a microwave power of 5 mW and a modulation amplitude of 0.4 mT.
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2.9.2 Spectral fitting
EPR simulations were performed using EPRSIM-C developed by Strancar et al.25
In an aqueous environment, the nitroxide label can freely rotate in any given x, y or z
direction giving rise to a sharp three-line spectrum. The rotational correlation time (τ c)
corresponds to the average time it takes to rotate on a single axis before changing directions
and can be directly correlated to the hyperfine coupling tensor A and the linewidth of the
central line. An isotropic label-label exchange (LLE) model was used to determine the
appropriate fitting parameters for free 16-DSA, including the rotational correlation time
(c), spin exchange rate (Wex), and corrections for polarity. The parameters for OleT-JEbound 16-DSA were determined using a stoichiometric enzyme:substrate complex fitted
to an anisotropic tumbling model (MES) that accounts for the restricted rotational motion
of the label with a partial averaging of all rotations. These parameters were determined
individually for wild-type OleT-JE and the F-G helix mutants. For the simulation of
spectra following the addition of H2O2, the spectra were decomposed into two components
(the bound and free label) using fixed parameters for each species but allowing the weight
of each to vary. The goodness-of-fit for all simulations was determined as 2 < 10,
representing a 95% confidence interval.

3. Results

3.1 Fluorescent- and EPR-active fatty acids are competent OleT-JE substrates
In order to ensure that the labeled fatty acid (FA) analogs utilized in this study
report on structural configurations that are similar to those of prototypical OleT-JE
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substrates, the binding and metabolism of the fluorescent FA probe 11-(dansylamino)undecanoic acid (DAUDA) and the EPR-active 16-doxylstearic acid (16-DSA) were
measured using transient and steady-state methods.

The structures of these probes are

shown at the top of Figure 2.1. The addition of either FA analog to substrate-free OleT-JE
resulted in a shift of the Soret maximum from 418 to 392 nm, resulting from the conversion
of the enzyme from the low- (LS) to high-spin (HS) ferric state that arises from
displacement of the axial water ligand (Figure 2.1A and 2.1B). The measured efficiencies
for high-spin conversion at saturating substrate concentrations, roughly 70% for DAUDA

Figure 2.1 Structure of the (A) 11-(dansylamino)undecanoic acid (DAUDA) and (B) 16doxylstearic acid (16-DSA) probes utilized in this study (top). UV-Visible binding
titrations of DAUDA and 16-DSA with wild-type OleT-JE. The optical changes at 418 nm
were fit to a Morrison tight-binding quadratic expression to determine the dissociation
constant of each probe with the enzyme (inset).
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and 85% for 16-DSA respectively, are comparable to FA substrates of similar chain
lengths. The readily observable absorption changes at 418 nm were used to measure the
dissociation constant (KD) of both molecules with OleT-JE (Figure 2.1 inset). Typically,
the binding free energy of FA substrates to OleT-JE scales with chain length (CL).

9, 18, 23

The KD values of the probes, summarized in Table 2.1, show a similar trend and have
affinities that are very comparable to prototypical long (e.g. C20 in the case of 16-DSA)
23

and short (C10 and C12 for DAUDA)

18, 23

9,

FA substrates that are efficiently

decarboxylated by the enzyme. The high-affinity and efficient propensity for spin-state
conversion suggest that the probes utilized in this study may adopt very similar
configurations within the active-site pocket as OleT-JE substrates. The precise mechanism
for substrate-assisted iron-oxo formation from H2O2 in CYP152 enzymes has yet to be fully
clarified. However, it has been proposed, based on analogy to a similar role proposed for
an active-site glutamate for chloroperoxidase (CPO)

26-27

and unspecific peroxygenases

(UPO),28 that the substrate-acid is required to facilitate the proton-mediated rearrangement
of the ferric-peroxide intermediate through either a hetero- 29 or homo-lytic 30 pathway that
generates Compound I.

Both mechanisms rely on the positioning of the substrate-

carboxylate in close proximity to the heme-iron for the iron-oxo intermediate to rapidly
form, in accordance with transient kinetic studies of OleT-JE. 9-10, 18 The OleT-JE:DAUDA
and OleT-JE:16-DSA ternary complexes were rapidly mixed with varying amounts of
H2O2, and the reactions were monitored using stopped-flow absorbance spectroscopy. The
photodiode array spectra obtained when using a large excess of H 2O2 (5 mM) to trigger the
reaction are shown in Figures 2.2A, 2.2B, 2.3A and 2.3B. In both reactions, the high-spin
signal had completely disappeared within the 1 millisecond deadtime and was replaced by
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traces of Compound I but predominantly the Compound II and ferric low-spin forms of the
enzyme. The kinetics for the formation and decay of the Ole-I and Ole-II intermediates
were followed at 370 nm and 440 nm. All single wavelength time courses were biphasic
in nature and could be fit using two-summed exponential expressions (Figures 2.2 and 2.3,
C and D).

Figure 2.2 Transient kinetic studies of the reaction of the OleT-JE:DAUDA ternary
complex and H2O2 at 4 oC. Concentrations after mixing were 6 µM and 5 mM respectively.
(A, B) Photodiode array spectra show the rapid decay of OleT-JE Compound I (Ole-I) to
Compound II over 12 ms followed by the decay of the latter species to the ferric low-spin
resting state of the enzyme over 200 ms. (C, D) The decay rate constants of the Ole-I and
Ole-II intermediates were measured using a two-summed exponential expression. The
decay rate constant of Ole-I (using the first phase at 440 nm or 370 nm) was 400 ± 40 s-1,
and the decay of Ole-II (using the decay phase of the 440 nm trace) was 13 ± 2 s-1.
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Figure 2.3 Transient kinetic studies of the reaction of the OleT-JE:16-DSA ternary
complex and H2O2 at 4 oC. Concentrations after mixing were 5 µM and 5 mM respectively.
(A, B) Photodiode array spectra show the rapid decay of OleT-JE Compound I (Ole-I) to
Compound II over 5 ms followed by the decay of the latter species to the ferric low-spin
resting state of the enzyme over 200 ms. (C, D) The decay rate constants of the Ole-I and
Ole-II intermediates were measured using a two-summed exponential expression. The
decay rate constant of Ole-I (using the first phase at 440 nm or 370 nm) was ≥ 700 s-1, and
the decay of Ole-II (using the decay phase of the 440 nm trace) was 9 ± 1s-1.

As in reactions of C20 10 and C12 18 FAs, there was excellent agreement between the
measured reciprocal relaxation times (RRT) corresponding to the decay of Ole-I,
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monitored at 370 nm, and the formation of Ole-II at 440 nm, reflecting a direct conversion
of the two species. The apparent rates for Ole-I decay were 400 ± 40 s-1 for DAUDA and
in excess of 700 s-1, the fastest RRT that can be accurately measured, for 16-DSA. The
rate constants for Ole-II decay were 13 ± 2 s-1 and 9 ± 1 s-1 respectively. The ability of the
probes to efficiently trigger the activation of H 2O2 was further evaluated by plotting the
RRT corresponding to Ole-II formation at 440 nm versus H2O2 concentration. In both
cases, the plots revealed a linear relationship with the concentration of oxidant and a nonzero y-intercept (Figure 2.4). We have interpreted this kinetic behavior, which differs from

Figure 2.4 H2O2 concentration dependence of Ole-II formation. The OleT:DAUDA or
OleT:16-DSA complexes were mixed in a 1:1 ratio with varying concentrations of H 2O2
and the reaction was monitored at 440 nm. The reciprocal relaxation time (RRT)
corresponding to Ole-II formation was obtained from a two-exponential fitting of the timecourse and was plotted vs. H2O2 concentration. Both substrates showed a linear
relationship and a k1 = 585 ± 22 mM-1 s-1 (16-DSA) and 176 ± 4 mM-1 s-1 (DAUDA) were
obtained from the slopes of the plots. The y-intercept provides the off-rate for H2O2
binding, k-1 = 33 ± 8 s-1 (16-DSA) and 9 ± 2 s-1 (DAUDA). These values are used to
𝐻 𝑂
calculate the apparent dissociation constants (𝐾𝐷 2 2 ) shown in Table 2.1.
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deuterated substrates that instead exhibit a hyperbolic dependence, as resulting from more
facile cleavage of the C-H bond and at least partially rate-limiting H2O2 activation. The
rate constants derived from these plots provide a peroxide on- (k1) and off-rate (k-1) that
are listed in the legend of Fig. 2.4. These rates were subsequently used to calculate an
𝐻 𝑂

apparent dissociation constant for H2O2 (𝐾𝐷 2 2 ). The values, shown in Table 2.1, are very
similar to those measured for other OleT-JE substrates. This intimates that the carboxylate
of DAUDA (or 16-DSA) enters the active site and very likely adopts a typical binding
mode whereby it is stabilized via electrostatic interactions with an active site arginine
(Arg245 in OleT-JE), a configuration that is common to all CYP152 enzymes that have
been structurally characterized to date. 11, 23, 31
Table 2.1. Comparison of equilibrium substrate dissociation constants and kinetic
parameters for H2O2 activation for wild-type OleT-JE with the probe molecules used in
this study and prototypical long- and short-chain length fatty acids.
Substrate
DAUDA
16-DSA
C20
C12
C10

K D Substrate
(μM)
2.3 ± 0.7
< 0.1
0.1 – 0.39, 23
2.8 ± 0.4
25 ± 8

High-Spin
Heme (%)
70
85
> 959, 23
61
19

K D (H2O2)
(μM)
45 ± 5
54 ± 20
10010
n.d.
81 ± 23

Reference
this study
this study
9, 10, 23
18
18

The DAUDA and 16-DSA probes were further evaluated as substrates for OleT-JE
using steady-state methods. After the controlled addition of H 2O2 over one hour to a
reaction mixture containing the wild-type enzyme and DAUDA, the metabolites were
analyzed through liquid chromatography mass spectrometry (LC-MS). The absorbance
chromatograms and MS profiles of products are shown in Figure 2.5A and 2.5B. DAUDA
was completely metabolized by the enzyme and was converted to a single product that
eluted later than the substrate. The MS chromatogram of the product (m/z = 389), 46 mass
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units smaller than DAUDA, was diagnostic for an alkene that formed from a
decarboxylation reaction.
Turnover studies of 16-DSA resulted in a slightly more complex profile of
metabolites. Following extraction and derivatization by trimethylsilylation, the resulting
products were analyzed by gas chromatography (GC). Assignments were made based on

Figure 2.5 Wild-type OleT metabolism of DAUDA and 16-DSA. Liquid chromatography
absorbance chromatograms of the metabolism of DAUDA (A) and mass spectral
fragmentation pattern of the decarboxylated DAUDA product (B). Gas chromatogram of
the reaction of 16-DSA following extraction with CHCl3 and trimethylsilylation (C). The
peaks that are designated by asterisks were also present in control reactions where H 2O2
was omitted.
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the characteristic retention patterns we have made for unlabeled FA substrates in prior
studies.18-19 Formation of the alkene product, 15-doxyl-pentadecene, was accompanied by
fatty-alcohols that were equally distributed at the C and C positions.
In sum, the product distributions from both labeled substrates confirm that the
chemoselective and regioselective features of the enzyme are largely preserved for the
probes despite the addition of the bulkier dansyl- and doxyl- groups appended to the FA
tail (Table 2.2).
Table 2.2. Metabolic profiles of the OleT-JE wild-type and mutant enzymes in steadystate turnover studies of the DAUDA and 16-DSA reporter probes following analysis by
LC-MS and GC. Alcohol and alkene products are expressed as a fractional percentage of
total products formed. The composition of individual alcohol products is shown in
parentheses. The C regiospecificity is defined as the fractional percentage of alkenes and
C alcohols over total products formed by the enzyme.
Enzyme

Substrate

Alcohol
(%)

Alkene
(%)

Wild-Type

DAUDA

0

16-DSA

L176G

∆3aa

Conv.
(%)

100

C Regioselectivity
(%)
100

72.2
(0 % , 52% ,
48 % 

27.8

65.3

29.1

DAUDA

47.5
(n.d.)

52.5

n.d.

98.3

16-DSA

100
(18 % 65 % 
17 % 

0

65.0

45.9

DAUDA

73
(n.d.)

27

n.d.

28.0

16-DSA

100
(0 % 95 % 
5 % 

0

95.0

87.0
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100

n.d. MS methods do not resolve the absolute regiospecificity of the DAUDA alcohols,
but place the major hydroxylated species at C or further

3.2 Conformational changes and slow product-release in the metabolism of
DAUDA
The solvatochromic nature of the dansyl fluorophore of DAUDA was used as a
reporter for any structural changes that may accompany binding or metabolism by OleTJE. The emission profile of free DAUDA upon excitation at λex = 340 nm is compared to
that of the probe when it is bound to the enzyme. The latter was prepared through the
addition of a small molar excess of DAUDA to OleT-JE followed by desalting unbound
probe. As a result, the fluorescence spectra only reflect the emissive properties of the
bound substrate. In an aqueous environment, the dansyl group has an emission maximum
(λem) ~ 560 nm. The emission spectrum of free DAUDA in aqueous buffer is shown in
Fig. 2.6A as a reference (grey spectrum). When the environment surrounding the dansyl
group becomes less polar, the λem typically shifts to a lower wavelength and is often
accompanied by a large increase (as much as 50-fold) in emission intensity. Such changes
have been well-documented for the binding of DAUDA to hydrophobic sites in proteins
such as albumin. 32 The maximum emission wavelength of the OleT-JE:DAUDA complex
exhibits a 60 nm red-shift to λem ~ 500 nm but the fluorescence intensity remains relatively
unchanged relative to that of the free probe (Fig. 2.6A, red spectrum). Immediately upon
the addition of H2O2 to the enzyme:substrate complex, however, a large increase in the
fluorescence (approximately 5-fold) was observed (Fig. 2.6A, blue spectrum). The origin
for the apparent structural rearrangements that occur during the turnover of DAUDA was
further probed by stopped-flow fluorescence measurements at 4 oC. In order to specifically
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probe the fluorescence of the bound DAUDA during catalysis and to minimize possible
photobleaching, a Förster resonance energy transfer (FRET) approach was used. At least
8 tryptophans are estimated to be within the 20 Å Förster distance to the dansyl group and
were used as donors (λex = 280 nm, λem ~ 300 nm) to excite DAUDA when it was bound in
close proximity. Rapid mixing of the DAUDA:OleT-JE complex with excess H2O2 under
conditions that matched those of the stopped-flow absorption experiments described earlier
(5 mM H2O2 post-mix at 4 oC) revealed a relatively rapid increase in fluorescence intensity
(k ~ 1.8 s-1) followed by a much slower rate of decay (k ~ 0.1 s-1) that could be approximated
by a two-summed expression (Figure 2.6B). The RRT for the loss of fluorescence in
particular is much slower than that measured for the rate limiting step (Ole-II decay) from
stopped-flow absorption measurements of the DAUDA single turnover reaction.

Figure 2.6 Fluorescence changes in the OleT metabolism of DAUDA. (A) Comparison
of the emission spectra of a 35 μM solution of DAUDA in solution (grey), bound to OleT
(red), and immediately following the addition of 5 mM H 2O2 to initiate decarboxylation.
(B) Rapid mixing of a 10 μM OleT:DAUDA with 5 mM H2O2 at 4 oC. The fluorescence
time-course is fit to a two-summed exponential expression. The observed rates associated
with large fluorescence changes are plotted as a function of H 2O2 (inset).

55

If either phase in the transient fluorescence profile corresponds to a step in the reaction that
follows the irreversible abstraction of the substrate Cβ hydrogen atom, it should be
kinetically separated from the H2O2 binding event. The inset to Figure 2.6B shows that
this is indeed the case and that both rates are insensitive to oxidant concentration.

3.3 The OleT-JE F-G loop regulates product egress
The increase in fluorescence during DAUDA metabolism by OleT-JE is most easily
interpreted as a change in the local environment of the dansyl probe that is coincident with,
or shortly follows, the decay of Ole-II. This is proceeded by the slow release of the product
from the enzyme, resulting in a large loss of FRET efficiency. Intriguingly, sluggish
steady-state turnover rates (~ 0.2 s-1) have been measured for the turnover of palmitic acid
(C16) by OleT-JE.

7

This is several orders of magnitude slower than the rate of

hydroxylation of myristate (C14) by the CYP152 hydroxylase P450 BS33 A pairwise
comparison of the crystal structures of eicosanoic (C 20) acid-bound OleT-JE23 and the
palmitate- (C16) bound BS hydroxylase11 reveal interesting differences in FA coordination
(Figure 2.7).

In particular, the binding of the longer CL substrate in OleT-JE is

accommodated by an F-G loop that is two amino acids longer than that of the corresponding
region of BS. In OleT-JE, a hydrophobic interaction between L176 and the FA helps to
reinforce a kink in the substrate acyl-chain that originates at the C12 position. Provided that
the binding of DAUDA adopts a similar arrangement, as steady state and transient studies
would seem to indicate, the surrounding polarity of the dansyl fluorophore would be
expected to be largely influenced by L176 and neighboring residues.
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Figure 2.7 Comparison of the crystal structures of (A) eicosanoic acid-bound OleT (PDB:
4L40) and (B) palmitate-bound cytochrome P450 BSβ. The C12 position of the substrate
is indicated as well as L176 on the FG loop. (C) Sequence alignment of the F-G loop and
adjoining F and G helices of OleT and BSβ. The sites of mutagenesis explored in this study
are indicated.

The F-G loop and adjoining helices have been shown to undergo large structural
changes in several CYPs including CYP101,34-37

P450 BM3,

38-39

CYP119,40 and

CYP2B4,41 upon the binding of substrate. In addition to playing a crucial role in regulating
substrate access, recent mutagenesis studies by Arnold and colleagues, guided by
molecular dynamics calculations, have shown that relatively minor substitutions in this
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flexible region also influence CYP regiospecificity. 42 For OleT-JE, turnover studies
conducted by several laboratories have shown that the chemoselectivity of the enzyme
generally shows a bimodal distribution with substrate CL.

The enzyme efficiently

decarboxylates long (C18 – C20) and short (C10) CLs but the metabolism of C12 – C16
substrates is accompanied by the production of variable amounts of fatty-alcohols,
typically at the Cβ position.

7, 9, 13, 17-18, 23

This implies that additional anchoring of the

substrate from the F-G loop may be an important point of contact for controlling the
chemical outcome, particularly for mid-CL substrates. A relatively conservative mutation
was generated that was designed to limit van der Waals interaction between the F-G loop
and the FA (L176G). This was accompanied by the design of a triple-deletion mutant
(ΔA179, ΔF180, ΔS186) to approximate the loop structure of BSβ by removing the extra
two residues of the FG loop and adjoining G-helix (Figure 2.7C). For simplicity, we refer
to the latter construct as Δ3aa hereafter. Both mutants were successfully expressed and
purified and exhibited typical low-spin heme spectra. The binding of eicosanoic acid (EA),
DAUDA, and 16-DSA was tested by optical absorption spectroscopy. Unlike the wildtype enzyme, all three substrates failed to induce any significant spin-shift in the L176G or
Δ3aa OleT-JE mutants (Figure 2.8). To verify that the variants did not introduce any
wholesale structural changes that eliminated FA binding altogether, the FRET approach
was used to interrogate the binding of DAUDA to OleT-JE. Upon the addition of the
fluorescent substrate, efficient quenching of the tryptophan fluorescence at 300 nm was
observed and accompanied by an emission from DAUDA at λem ~ 500 nm (Figure 2.9A).
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Figure 2.8 Optical absorption spectroscopy of the L176G and Δ3aa mutant in the absence
(black) and upon the addition (red) of various fatty acids. (A, B) 50 μM eicosanoic acid;
(C, D) 50 μM 16-DSA; or (E,F) 300 μM DAUDA was added to 12 μM OleT. The 350 nm
absorbance in E and F derives from excess free DAUDA.
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Figure 2.9 Fluorescence titration studies of wild-type (WT), L176G, and Δ3aa OleT-JE
with DAUDA. The fatty acid was titrated into 5 µM OleT-JE and the emission spectrum,
using λex = 280 nm was collected. The fluorescence intensity at 500 nm was plotted as a
function of DAUDA concentration and dissociation constants (KD) were determined by
fitting the data to a Morrison quadratic function.

Using the FRET response as a binding-probe, the dissociation constants of DAUDA with
wild-type OleT-JE and the two variants were measured. The KD values were similar for
all three enzymes, demonstrating that the variants were able to bind the labeled-FA with
an affinity comparable to wild-type OleT-JE (Figure 2.9B-D). The L176G:DAUDA and
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3aa:DAUDA complexes were subsequently mixed with excess H2O2 under the same
conditions used for the wild-type enzyme in Figure 2.6, and the fluorescence at em > 500
nm was monitored by stopped-flow fluorescence.

Both mutants exhibited a drastic

reduction in the maximal emission intensity that could be observed.

Notably, the

fluorescence decay was also much faster in the mutants (Figure 2.10). This implies that
the structural changes accompanied with formation of the stable enzyme:product complex
in the wild-type enzyme either did not occur or were much more transient in nature,
resulting in more facile release of product from the active site.

Figure 2.10 Transient fluorescence changes upon rapid mixing of a wild-type (black),
L176G (red) or Δ3aa (blue) OleT-JE:DAUDA ternary complex with excess H2 O2 at 4 °C.
Concentrations of OleT-JE and H2O2 were 10 uM and 5 mM after mixing respectively. An
excitation wavelength of 280 nm was used and fluorescence was collected using a 510 nm
bandpass filter.
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The longer 16-DSA substrate was used as an auxiliary probe to verify the influence
of the F-G loop on the substrate-coordination and product release steps. The electron
paramagnetic resonance (EPR) spectrum of the doxyl-linked FA is particularly sensitive to
the local environment at the nitroxide label. The EPR spectra of OleT:16-DSA complexes,
prepared with the wild-type and L176G and 3aa OleT mutants, are shown in Figure 2.11.
The anisotropic broadening of the spectra and diagnostic shift of the low-field signal,
relative to that of free 16-DSA in solution, verified that like DAUDA, the loop mutants are
fully capable of binding the FA analog. Fitting of the spectra for the OleT:DAUDA
complexes using an anisotropic model (Table 2.3) provided rotational correlations times
(RCT or c) for the bound probe.
Table 2.3: Fitting parameters for free 16-DSA in solution and for the OleT:16-DSA
complexes using EPRSIM-C. An isotropic label:label exchange (LLE) model was used to
fit the spectrum of free 16-DSA and an anisotropic tumbling model (MES) that accounts
for restricted rotational motion of the nitroxide-label was used to fit the OleT:16-DSA
complexes.

Free 16-DSA

Wild-Type

Δ3aa

L176G

Parameter
Tc
0.112 ns
W
1.5 G
4G
4G
4G
Wex
0.943 G
Pa
1.0778
1.0021
1.0021
1.0018
Pg
0.99985
thθ
0.55 rad
0.5 rad
0.52 rad
fiθ
0.33 rad
0.42 rad
0.4 rad
tc
0.383 ns
0.383 ns
0.338 ns
Pr
-0.07
-0.07
-0.067
Tc = isotropic tumbling time; W = broadening constant; Wex = spin exchange rate; Pa, Pg =
polarity correction terms; thθ = main cone angle; fiθ = asymmetry angle; t c = effective
rotational correlation time; P r = proticity
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The 16-DSA:OleT complexes exhibit very similar RCTs (c ~ 0.4 ns) that are significantly
higher than that of 16-DSA in solution (c ~ 0.1 ns). Nonetheless, these RCTs are
considerably smaller than those measured for other FA-binding proteins such as
lipoxygenase 43 or serum albumin 44 (c > 10 ns). The enhanced mobility suggests that the
longer acyl chain (relative to DAUDA) allows the probe to fluctuate around the entry-point
of the binding channel of OleT. However, the doxyl group is largely unrestricted in nature.

Figure 2.11 Room temperature electron paramagnetic resonance spectra of 16-DSA:OleTJE complexes prepared with the wild-type (top), L176G (middle), or Δ3aa mutant enzymes
(black). The spectral fitting procedures using EPRSIM-C are described in the methods. The
parameters used for fitting are provided in Table 2.3

63

The ability to readily delineate between the EPR spectra for the bound- and freeDSA probe provides, in principle, a way to determine if the F-G loop synchronizes the
release of a longer CL product that more closely approximates native metabolism. The
OleT:16-DSA complexes were mixed with varying amounts of H 2O2, and EPR spectra
were collected after incubation for one hour at 4oC. Simple spectral addition procedures
using the component spectra allowed a determination of the fraction of the label bound to
the enzyme, presumably as a product form (Figure 2.12).

Figure 2.12 EPR spectra of wild-type (A-C), L176G (D-F), and Δ3AA OleT:16-DSA
complexes following the addition of 5 (A, D, G), 10 (B, E, H), or 30 molar (C, F, I)
equivalents of H2O2 and incubation for one hour. The data (black) were fit to bound- (pink)
and free- (blue) components using differential weighting of the spectral fitting parameters
listed in Table S1.
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Although these approaches do not provide as direct of a kinetic read-out for product
egress as DAUDA fluorescence, the results clearly show that slow product release is a
general feature of OleT and does not solely result from the attached probe (Figure 2.13).
For example, despite the addition of 30 molar equivalents of H2O2 to wild-type OleT:16DSA, the vast majority of the probe (> 95 %) remained bound to the enzyme. In contrast,
paired reactions with the L176G and 3aa mutants resulted in a much larger fraction (> 40
%) of the free probe after incubation with the oxidant. Taken together with the fluorescence
data and the relatively sluggish steady-state rates for OleT turnover, this implies that

Figure 2.13 Fraction of 16-DSA bound to wild-type (WT), L176G, and Δ3aa after
incubation of the enzyme:substrate complex with H2O2 after one hour at 4oC. The fraction
bound was determined from spectral addition procedures using the fitting parameters
determined for the free and bound labels. The inset shows an example of these fitting
procedures after the addition of 30 equivalents of H 2O2 to the enzyme:substrate complex.
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structural changes at the F-G loop serve to limit the rate of product egress and that this may
represent the overall rate-limiting step in OleT catalysis.

3.4 Distal control of OleT-JE chemo- and regio-selectivity
Despite lacking a spin-shift, it is evident from the FRET responses upon the
addition of DAUDA and the EPR spectra of the OleT:16-DSA complexes, that FA
substrates are capable of binding to both the L176G and 3aa variants. In the absence of
any long-range coordinated effects on the cysteine proximal ligand, which would seem
unlikely, this implies that the F-G loop may also influence the binding-modes of substrates
or alter the mobility of FAs within the OleT pocket, resulting in more active site hydration.
The lack of high-spin conversion with the mutants precludes the detection of Ole-I and
Ole-II intermediates, as the hexacoordinate low-spin enzyme only reacts slowly with H2O2.
The array of products formed by the mutants, however, is highly revealing. The metabolic
profiles of the labeled FAs and OleT mutants are shown in Table 2 to facilitate comparison
with the wild-type. LC-MS analysis of the products obtained from DAUDA metabolism
revealed a mixture of at least three new products that were more polar than the substrate
(Figure 2.14).
MS of these new species revealed a parent ion at m/z = 451, consistent with
introduction of a hydroxyl group, and a progressive decrease in the level of alkene from
wild-type, to L176G, to 3aa. MS/MS analysis of the alcohols places the regiospecificity
of C-H abstraction for most of the alcohol products at the C-H position or further.
However, absolute assignment is not possible. Nonetheless, it is evident that introduction
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of the loop mutations predisposes OleT towards hydroxylation. The combined loss of
anchoring from the substrate-dansyl group and the F-G loop led to more dramatic
alterations in the chemoselectivity of 16-DSA oxidations.

Figure 2.14 Metabolism of DAUDA by the L176G and Δ3aa OleT mutants. Liquid
chromatography absorbance chromatograms of the metabolism of DAUDA (A) and mass
spectral fragmentation pattern of the decarboxylated and hydroxylated FA products.
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The products from 16-DSA metabolism showed a progressive increase in the total turnover
numbers for L176G and 3aa, consistent with more efficient steady-state turnover rates
due to an acceleration of the product release step.

Rather than exhibiting mixed

chemoselectivity, GC analysis only revealed the presence of fatty-alcohol metabolites,
even though the C regioselectivity of C-H abstraction was largely retained.
The products generated from more traditional FA substrates revealed even more
dramatic alterations on the array of products formed (Figure 2.15).

The product

distributions of the wild-type enzyme are very similar to those recently reported by Munro
and colleagues, and demonstrate that even though OleT is capable of decarboxylating a
broad range of substrates, the metabolism of C12 – C16 FAs is accompanied by the presence
of a significant fraction of C-alcohols. 13 The L176G mutant results in a tangible loss of
decarboxylation activity. With substrate CLs ≤ C 14, the enzyme exclusively hydroxylates
substrates. Loss of stabilization from the F-G loop also results in a significant loss of
regiospecificity. For the C12 FA substrate, alcohol products were observed that extended
as far as the C position. A significant fraction (~30 %) of new metabolites were detected
that eluted much later than alcohols and had masses (m/z = 415) much larger than those
expected for single oxidations. Results from the 3aa mutant were comparable to the
single amino acid variant. A complete loss of decarboxylation activity occurred with
substrates with a CL of C16 and lower and wide distribution of fatty alcohol products, many
at positions far-removed from the carboxylate-head, were observed.
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Figure 2.15 Metabolic profile of wild-type (WT), L176G, and Δ3aa OleT-JE with Cn chain
length fatty acid substrates
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4. Conclusions
We have shown that very subtle alterations on the substrate or protein, at positions
quite far from the site of chemistry, can have profound effects on the partitioning of
decarboxylation and hydroxylation chemistries in OleT. The FA probes utilized here have
revealed a previously unidentified slow product release step that limits turnover by this
family of enzymes. Although this slow step can be alleviated through targeted mutagenesis
of the F-G loop, such alterations come with a significant price. A single amino acid change
in this region converts OleT into a hydroxylase and has significant impact on the
regiospecificity of C-H abstraction. This work provides the most compelling evidence to
date that the coordination of substrate and a restriction of its mobility within the active site
is the most important element for regulating chemical outcome in this family of enzymes.
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CHAPTER 3
STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF A
P450 DECARBOXYLASE FROM STAPHYLOCOCCUS AUREUS

Abstract
In the last decade, much effort has been placed in understanding the mechanisms
of decarboxylation and hydroxylation in the cytochrome P450 OleT JE. Recent work in our
group has described the role of the F-G loop in substrate stabilization and its importance in
the efficient decarboxylation of fatty acids. Furthermore, we have demonstrated that
decarboxylation in OleTJE proceeds through the prototypical ferryl-heme intermediates of
P450s. The unusual stability of these transient species is evidence of their role in
chemoselectivity; understanding how they are stabilized in the protein framework is a
primary focus of our research. Here, we present the structural and functional
characterization of an OleTJE homolog from Staphylococcus aureus (OleTSA) that readily
performs C-C bond scission on a broad range of substrates. The crystal structure of
eicosanoic-acid bound OleTSA shows the retention of the important secondary elements
necessary to suppress oxygen rebound. Moreover, we discuss how the improved stability
of the protein at high concentrations will allow the characterization of the catalytically
relevant intermediates in decarboxylases of the CYP152 family of P450s.
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1. Introduction
Olefin production has become one of the most important processes in the chemical
industry. As a building block for many products that are used daily, its demand is
exponentially growing and does not show any signs of halting. Olefin preparation is mainly
accomplished through a steam cracking process, in which the hydrocarbons primarily
found in fossil fuels are broken to produce smaller olefin molecules.2 Although highly
efficient, this process requires the input of high temperatures and environmentally harsh
conditions. A recent study by Ghanta et al.3 demonstrated that fuel burning, necessary to
produce these conditions, accounts for almost 90% of greenhouse gas (GHG) emissions in
the process of ethylene production. As we approach critical levels of GHG, finding
alternative techniques to produce alkenes are becoming essential. Alternative routes to
produce olefins, like the methanol-to-olefin process (MTO), have been well developed in
the past decades; however, they have very poor carbon efficiencies and thus produce
immense quantities of GHG.2
Intense interest has been put in the research and development of platforms to produce
valuable molecules from microorganisms. The so-called advanced generation of biofuels
is becoming more viable everyday with the immense growth of biodiesel production from
algae.4 Another method in development is the use of bacteria to produce valuable
molecules by hijacking their natural biosynthesis pathways. The engineering of
recombinant proteins capable of catalyzing difficult chemistry like C-C bond cleavage has
turned these processes into a possible route to replace the extreme conditions necessary in
current industrial processes.5-6 A clear example of this has been the engineering of aldehyde
deformylating oxygenase (ADO) from cyanobacteria into E. coli, which converts fatty
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aldehydes into alkanes and formate.7 Although much effort has been placed in the
development of enzymes capable of such chemistry, there is still much to be done for these
systems to become economically viable.
In 2011, OleTJE, an enzyme isolated from the Jeotgalicoccus sp., species was shown to
produce terminal olefins from fatty acids, a cheap substrate found in abundance in bacteria
such as E. coli.8 Although very efficient in the production of long-chain olefins, OleTJE is
less efficient in metabolizing shorter substrates into terminal alkenes. 3,

9

This is a

requirement in the chemical industry as the most valuable olefins tend to be shorter in chain
length.2 As a part of the CYP152 family of cytochrome P450s, OleT JE is the only P450 that
can efficiently decarboxylate a substrate yet also catalyze monooxygenation.8, 10-11 In fact,
as the chain-length is decreased, the chemistry tends to be rerouted onto the hydroxylation
pathway. In recent years, great effort has been placed in understanding the catalytic
determinants of decarboxylation in OleTJE as it could help harness its powerful chemistry
to deploy it in an industry setting. We have shown in our group that C-C bond cleavage in
this family of P450s is finely regulated by small modifications in the structure of the protein
that extend as far as 17 Å from the active site.12-13 Furthermore, we have demonstrated that
decarboxylation proceeds in a similar manner as prototypical P450s with the formation of
the canonical intermediates compound I and compound II. 14-15 These powerful ferryl heme
oxidants have been shown to be extremely short-lived in most P450s. In OleTJE, their
stabilization is of great importance as decarboxylation requires the redirection of the typical
“oxygen rebound” chemistry of compound II into what is believed to be the formation of a
carbocation substrate through a proton-coupled electron transfer (PCET) pathway.15
Analysis of the electronic structure of these intermediates in order to understand how they
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are stabilized has proven to be a challenge in OleT JE as their study requires the
implementation of advanced spectroscopy such as rapid freeze-quench EPR and
Mössbauer, both requiring high protein concentrations. Although well behaved at low
concentrations, OleTJE becomes highly unstable at high concentrations preventing the use
of these spectroscopies for their study.
In this manuscript, we present the biochemical and structural characterization of OleTSA, a
new ortholog of the CYP152 family of P450s from Staphylococcus aureus. This enzyme
has the same decarboxylation properties of OleTJE as well as highly similar kinetics of the
catalytically relevant intermediates. However, OleTSA exhibits improved solubility at high
concentrations and can be readily crystalized. The retained chemistry and improved
biochemical features of this enzyme will set-up a new platform to understand the
fundamentals chemistry in this family of proteins and uncovers common themes of
CYP152s that enable their implementation for the advanced generation of biofuels.

2. Experimental Procedures

2.1 Reagents and chemicals
All buffers used in this study were purchased from BDH Chemicals. Media
components (tryptone, peptone, yeast extract) and ammonium sulfate were acquired from
Research Products International (Mount Prospect, Il, USA). Antibiotics were purchased
from BioBasic Inc (Markham, ON Canada). Hydrogen peroxide and sodium molybdate
was purchased from Sigma Aldrich. The terminal alkene standard, 1-hexadecene was
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purchased

from

TCI

chemicals.

The

hydroxylated

fatty acid

standard,

2-

hydroxyhexadecanoic acid, was purchased from Combi-Blocks (San Diego, CA). Protiated
fatty acids and N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA)/trimethylchlorosilane
(TMCS) (99:1) were purchased from Supelco (Bellefonte, PA, USA). Deuterated fatty
acids were purchased from CDN Isotopes. All the crystallography material was obtained
from Hampton Reseach (Aliso Viejo, CA, USA). OleTSA gene was synthetized by Bio
Basic Inc (Markham, ON Canada).

2.2 Cloning, expression and purification of OleTSA
The original OleTSA gene was synthesized and codon optimized for E. coli
expression by Bio Basic Inc. (Markham Ontario). The gene was subcloned onto a
kanamycin-resistant T5 plasmid containing a C-terminal HisTag preceded by a TEV
cleavage site using NdeI/XhoI restriction sites. The plasmid was transformed onto
BL21(DE3) containing the pTF2 plasmid encoding for GroEL/GroES/Tig onto a
kanamycin/chloramphenicol LB plate. The next day, one colony was inoculated into 150
mL of modified Terrific Broth (12 g yeast extract, 6 g tryptone, 2 g peptone) supplemented
with 50 µg/mL kanamycin and 20 µg/mL chloramphenicol and grown overnight at 37 °C.
10 mL of starter culture were inoculated into 500 mL of modified terrific broth containing
50 µg/mL Kanamycin, 20 µg/mL chloramphenicol, 125 mg/L thiamine and trace metals.
The culture was initially grown for ~2 hours at 37 °C until OD 600nm = 0.6, at which point
the temperature was decreased to 18 °C until the OD 600nm reached 1.5. At this point,
cultures were induced with 100 µM IPTG, 10 ng/mL tetracycline and 10 mg/L of 5aminolevulinic acid and grown for an additional 15 hours at 18 °C. The following day,
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cultures were centrifuged 10 minutes at 6000 rpm and the pellet was resuspended in 4 mL
of Buffer A (50 mM KPi pH 8, 300 mM NaCl and 10 mM imidazole) per gram of pellet.
Cells were disrupted using a Branson sonifier and stirred for an hour before centrifuging
30 minutes at 16,000 rpm. The supernatant was loaded onto a previously equilibrated NiNTA column, washed with buffer A + 25 mM imidazole and eluted with buffer A + 250
mM imidazole. The eluate was diluted 1:1 with Buffer B (50 mM KPi pH 8, 300 mM NaCl
60 % ammonium sulfate) to reach a final concentration of 30 % ammonium sulfate. The
diluted protein was then loaded onto a previously equilibrated Butyl-S-Sepharose column,
washed with 10 column volumes of Buffer C (50 mM KPi pH 8, 300 mM NaCl and 30 %
ammonium sulfate) and eluted with a gradient over 8 column volumes from buffer C to
buffer D (50 mM KPi pH 8). Fractions with a 418nm/280nm ratio higher than 1 were pooled
and dialyzed against 50 mM KPi pH 8 200 mM NaCl in the presence of 0.1 molar
equivalents of TEV protease. The following day, protein was loaded onto a Ni-NTA
column equilibrated in dialysis buffer and the flow-through was directly added onto a QSepharose column equilibrated in the same buffer. The column was subsequently washed
with 20 column volumes of buffer E (50 mM KPi pH 8, 250 mM NaCl) and eluted with a
gradient over 8 column volumes from buffer E to buffer F (50 mM KPi pH 8, 750 mM
NaCl). Fractions with a 418nm/280 nm ratio higher than 1.2 were pooled and dialyzed against
200 mM KPi pH 8. The final yield was 60 mg of protein per liter of culture.
2.3 Spectroscopy
a) UV-Visible Spectroscopy
Optical spectra were obtained using an HP 8453 spectrophotometer. For substrate
titration experiments, 10 µM of protein in 200 mM potassium phosphate (KH2PO4) pH 7.5
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was titrated with sequential additions of a 1 mM fatty acid stock dissolved in 70% ethanol:
30% Triton X-100 (v:v). The following fatty acid stocks were used: eicosanoic acid (C20),
octadecanoic acid (C18), hexadecanoic acid (C16), tetradecanoic (C14), dodecanoic acid
(C12) and decanoic acid (C10). The amount of ethanol added never exceeded 5 % of the
total volume. Fitting of the substrate induced absorption changes, ΔAbs, (at 396 nm and
418 nm) were done with the Morrison equation for tight-binding ligands as previously
described.16 To discard the possibility that the spectral changes resulted from the binding
of Triton X-100 present in the fatty acid stock, a control titration was performed using a 70
% ethanol: 30 % Triton X-100 (v:v) stock in the absence of fatty acid. The resulting spin
shift was small enough to conclude the spin shifts resulted from the binding the fatty acid
rather than from Triton X-100.
b) EPR spectroscopy
All EPR samples were treated with 15 molar equivalents of hydrogen peroxide
(H2O2) and incubated at 4 °C for 30 minutes prior to preparation. After treatment, the
protein was desalted in 200 mM potassium phosphate (KH2PO4) pH 7.5 using a PD-10
desalting column to remove any excess hydrogen peroxide. Following buffer exchange,
samples were concentrated to 150 µM. For the substrate-bound forms, 1 molar equivalent
of eicosanoic acid dissolved in 70 % ethanol:30 % Triton X-100 (v:v) was added and
incubated for 1 hour at 4 °C. All the samples were flash-frozen and kept at liquid nitrogen
temperatures until further use. EPR spectra were recorded on a X-band Bruker EMXplus
spectrometer equipped with an Oxford Instruments liquid helium continuous flow cryostat.
Spectra were recorded at a temperature of 15 K, a power of 2 mW and an amplitude of 1
mT.
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2.4 P450 activity assays
Multiple turnover in vitro reactions of P450 with substrate were prepared in 2 mL
with the following contents pre-mix: 5 µM P450, 500 µM fatty acid dissolved in DMSO,
and 200 mM K2HPO4 pH 7.5. 1000 molar equivalents of H2O2 to P450 were stirred into
the 2 mL volume above at a rate of 2 mL/hr to a final volume of 4 mL. Steady-state
reactions were quenched with 0.5 mL of 12 M HCl after 1 hour. Fatty acid and oxidant
concentrations remained unchanged throughout multiple turnover reactions. Internal
standards including 1-hexadecene and a Cn-2 fatty acid relative to the substrate were added
to the quenched reaction. The reactions were extracted with an equal reaction volume of
chloroform. The organic phases of each reaction were concentrated under a stream of N 2
gas to less than 50 µL. Concentrated samples were derivatized with 250 molar equivalents
of BSTFA:TMCS (99:1). Samples were incubated at 60 °C for 20 minutes for
trimethylsilylation.

Following

derivitization,

samples

were

analyzed

by

Gas

Chromatography-Mass Spectrometry (GC-MS). GC-MS was performed at the University
of South Carolina Mass Spectrometry facility with a Hewlett-Packard HP5890 Gas
Chromatograph and an Agilent HP-5 column. The following oven conditions were used to
detect products of C20 through C16 fatty acids: 170 °C for 3 min., a 10 °C/min to 220 °C, a
5 °C/min to 320 °C, and 320 °C for 3 min. The following oven conditions were used to
detect products of C14 and C12 metabolism: 100 °C for 3 min., a 5 °C/min to 250 °C and a
250 °C for 3 min. The response factors between fatty acids, hydroxyl fatty acids and
alkenes were determined by analyzing known authentic fatty acids (C18-C10), 2hydroxyhexadecanoic acid, 1-hexadecene, and 1-undecene standards.
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2.5 Stopped-flow kinetics

a) Sample preparation
All P450s were prepared as previously described.14-15 Briefly, the enzyme
was peroxide-treated with 15 molar equivalents of hydrogen peroxide and desalted into
200 mM K2HPO4 pH 7.5 on a PD-10 desalting column. All proteins were concentrated and
diluted in 200 mM K2HPO4 pH 7.5 to a final concentration of 20 µM. Three molar
equivalents of either protiated or deuterated fatty acid was subsequently and incubated at
4 °C for at least 4 hours to allow proper fatty acid binding. A stock of 50 mM H2O2 was
prepared in K2HPO4 pH 7.5 and incubated at 4 °C for 4 hours.
b) Data collection
Stopped-flow experiments were carried out on an Applied Photophysics Ltd. SX20
stopped-flow spectrophotometer. Briefly, each protein stock was rapidly mixed 1:1 against
50 mM H2O2 to give a final concentration of 10 µM protein and 25 mM H 2O2 post-mix.
Single wavelength traces were collected using a photomultiplier tube (PMT) and full
spectral data was acquired using photodiode array (PDA) detection. The decay rates of the
catalytically relevant intermediates compound I and compound II were determined using
the ProData software package using the PMT traces at 370 nm, 440 nm and 690 nm as
previously described.14-15 The maximal accumulation of the intermediates was determined
using singular value decomposition (SVD) using ProKIV and the PDA data as an input.
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2.6 Crystallography
a) Initial screen
To assess initial crystallization conditions, the protein was sent to the HauptmanWoodward Medical Research Institute where 1536 conditions were tested (soluble screen
under oil).17 Prior to condition screening, the protein was purified as described above and
treated with 3 molar equivalents of eicosanoic acid (C 20). The protein was incubated at 4
°C for an hour and subsequently desalted in 200 mM K2HPO4 pH 7.5 to remove any excess
fatty acid substrate. The P450 was concentrated to roughly 10 mg/ml (~200 µM) and flashfrozen in liquid nitrogen.
b) Optimized conditions
Optimized crystals were grown using the hanging-drop vapor diffusion method.
Briefly, protein solution at 15 mg/mL was mixed 1:1 against reservoir solution (100 mM
HEPES pH 7.5; 100 mM sodium molybdate; 20% PEG 8000) in a total volume of 2 µL.
Crystal trays were incubated at 4 °C for two weeks before crystals appeared. Prior to
storage, crystals were soaked in reservoir solution supplemented with 20% glycerol as
cryoprotectant for 1 minute and subsequently cryo-cooled in liquid nitrogen. For the
product-bound forms, the crystal was soaked in reservoir solution + 20% glycerol
supplemented with either 1 mM hydrogen peroxide, 300 µM meta-chloroperbenzoic acid
(mCPBA) or 500 µM peracetic acid.
c) Data collection and processing
X-ray diffraction patterns were collected at the Advanced Photon Source (Lemont,
Il, USA), beamline 22-ID, through the Southeast Regional Collaborative Access Team
(SER-CAT). Data scaling and integration were done using the HKL-2000 software18
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package. Structure phasing was done by molecular replacement using the substrate-bound
OleTJE structure as a search model (PDB code: 4L40) in the Phenix Phaser program19.
Initial model building was performed using the Phenix Autobuilder 19 option and manual
refinement was done using Coot.20 Final refinement and validation was done through
Phenix Refine and Phenix Validate respectively. 19 Figures were generated using Pymol
Molecular Graphics software package (Version 1.3 Schrödinger LLC).

2.7 Solubility Assay
Protein solubility was determined using the method developed by Kramer R. et al.21
Briefly, 20 µM of substrate-free protein in 50 mM K2HPO4 pH 7.5 was treated with
increasing amounts of an ammonium sulfate solution (4 M) at pH 7.5. After each addition,
the aliquot was centrifuged to remove any aggregated protein and the absorbance at 418
nm was used to determine the concentration of protein remaining in solution. Taking into
account the dilution factor after each ammonium sulfate addition, the common logarithm
of the concentration of protein in solution was plotted versus ammonium sulfate
concentration. The theoretical solubility of the protein in 50 mM K2HPO4 pH 7.5 was
determined by extrapolation of the linear portion of each curve.

3. Results
Previous studies in our group have determined the overall reaction scheme for
decarboxylation, including the kinetics for the formation and decomposition of Compound
I and II intermediates in OleTJE.14-15 To better understand the origin for the relatively
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sluggish reactivity of these intermediates compared to other CYPs, which may be central
to reinforce substrate decarboxylation, it is crucial to study their electronic properties.
Advanced spectroscopy such as rapid freeze-quench EPR (RFQ-EPR) and Mössbauer
requires significantly higher protein concentrations (200 μM to 1 mM) than those used in
the transient absorption methods we have utilized previously. This has proven to be a
challenge in OleTJE, as the protein readily aggregates at these concentrations. To overcome
this, we sought to find an ortholog that would retain the essential active site residues
necessary for catalysis, but also exhibit improved biochemical properties. An amino acid
sequence comparison using the Basic Local Alignment Sequence Tool (BLAST) at NCBI
rendered more than 100 hits of proteins possessing 50 % or higher sequence identity to
OleTJE. From the multiple hits, a cytochrome P450 from Staphylococcus aureus was
chosen, henceforth named OleTSA, with an overall sequence identity of 64%. This protein
appears to have all the required catalytic components for fatty acid metabolism, including
but not limited to: His85, Ala369 and the extended F-G loop which we have previously
demonstrated to be required for efficient decarboxylation in this class of enzymes (Figure
3.1).9, 12 The active site sequence identity, defined as 10 Å from the catalytic heme-iron,
was found to be 95 %. This variation was within the required range for the study and
therefore was not expected to have a significant impact on the reactivity nor the
chemoselectivity of the enzyme.

3.1 Expression and purification of OleTSA
The gene with the NCBI reference sequence ID WP_049319149.1 was codon
optimized for E. coli expression and synthetized by Bio Basic Inc. The initial plasmid
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Figure 3.1 Partial sequence alignment of OleT JE and OleTSA using the Basic Local
Alignment Sequence Tool (BLAST) at NCBI. The red boxes correspond to residues that
have been shown to participate either in reactivity of in chemoselectivity of the final
product.
contained a lac promoter and was transformed into the BL21 E. coli strain; however, poor
protein expression and yields were obtained.
To overcome these issues, the gene was sub-cloned into a second vector containing
a T5 promoter and a kanamycin resistance cassette. The obtained plasmid was cotransformed into BL21(DE3) cells along with the pTF2 plasmid encoding the chaperones
GroEL, GroES and Tig, as it has been previously shown the enhancement of protein
expression and solubility in OleTJE.9, 12, 14-15 Initial expression trials revealed an elevated
expression of the protein in the soluble fraction. Residual amounts of protein were found
to be associated with the membrane but were discarded as the yields of the soluble fraction
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were sufficient for subsequent purification. A similar association to the membrane was also
observed in the purification of CYP-MP, and appears to be general for CYP152s that bind
highly hydrophobic substrates.13 OleTSA was initially purified using nickel nitriloacetic
acid (NiNTA) affinity and hydrophobic interaction chromatography (Butyl-Sepharose).
Modelling of the protein using the I-TASSER server predicted a disordered C-terminal
domain, similar to OleTJE.9 To facilitate crystallization, the polyhistidine tag was removed
by TEV cleavage, and the protein was subsequently loaded onto a nickel column to remove
TEV and the uncleaved protein. As a final purification step we purified the cleaved protein
on a Q-sepharose column and dialyzed it against 200 mM KPi pH 7.5. Using the extinction
coefficient at 418 nm ε418 nm = 112 mM-1cm-1 corresponding to the heme Soret band and the
predicted protein extinction coefficient at 280 nm, we were able to assess the final purity
of the protein. The final Reinheitszahl ratio (A418nm/A280nm ratio) was determined to be >
1.2. SDS-PAGE revealed a highly pure protein with a molecular weight of 52 kDa (Figure
3.2).

Figure 3.2 SDS-PAGE gel of OleTSA after a 3-column purification procedure. The
apparent molecular weight is consistent to that predicted for the TEV cleaved protein (52.4
kDa).
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3.2 OleTSA possess similar spectroscopic signatures to OleTJE
As it has been well established that the UV-Vis spectra of cytochrome P450s is
sensitive to the redox state of the heme as well as the primary coordination sphere.22 In the
absence of substrate, P450s display a Soret band with a maximum absorption between 418
nm and 422 nm depending on the nature of the 6th ligand of the heme (H2O versus OH-).13
Upon substrate binding, the sixth ligand is displaced and the Soret band blue-shifts to ~396
nm. UV-Vis spectroscopy of the as purified enzyme displays a maximal absorption at 418
nm with a shoulder at 396 nm, suggesting that OleT SA is purified with an adventitiouslybound substrate (Figure 3.3A). This is unsurprising as E. coli produces high amounts of
free fatty acids (particularly C16) in the cytoplasm and is a phenomenon that we12-14 and
others10-11 have noted for several CYP152 enzymes.

Figure 3.3 UV-Vis spectra of OleTSA. (A) Ferric form of the protein: in black as purified
and red hydrogen peroxide treated. (B) Ferrous form of the protein: black corresponds to
the reduced protein with dithionite and methyl viologen as a mediator; red corresponds to
the reduced form with addition of carbon monoxide.
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Upon substrate metabolism that occurs with the addition of hydrogen peroxide, the Soret
band shifts to a maximum absorption to 418 nm, indicative of restoration of a water
molecule as the 6th ligand to the heme iron. When the protein is reduced with 10 molar
equivalents of sodium dithionite, the intensity of the Soret band decreases and has a
maximum absorption at 408 nm typical of ferrous P450s (Figure 3.3B). The α and β Qbands merge into one distinct band at ~550 nm. The addition of carbon monoxide to the
reduced protein shifts the main absorption band towards 446 nm, indicating the formation
of the carbonmonoxy-bound form of the enzyme and preservation of the thiolate ligated
heme. These values are in accordance to what has previously been observed in OleT JE.9
Curiously, the CO-bound form of this enzyme appears to be much more stable in OleTSA,
and can persist as long as 1 hour. More in-depth studies are needed to confirm the cause
for the enhanced stability of the proximal ligand. However, it points towards enhanced
properties that can possibly be leveraged for in vivo generation of biofuels.
Similar to optical spectroscopy, the EPR spectra of P450s are also highly sensitive to
changes in the heme environment, including changes in the hydrogen bonding network and
geometry of the heme.22 As previously noted, the resting state of P450s involves a 6th ligand
bound to the heme, this maintains the Fe(III) center in a 6-coordinate low spin state (6cLS)
with an S = ½ giving rise to a rhombic signal usually centered at 2.25. The position of the
gx, gy and gz values is informative of the nature of the 6th ligand and the hydrogen bonding
network within the distal and proximal side of the heme. In the case of OleT SA (and
OleTJE),9 several gz’s can be detected (Figure 3.4A), suggesting a poorly structured
hydrogen bonding network on the distal side of the heme that leads to conformational
heterogeneity of the axial water ligand. The same phenomenon is observed in its ortholog.
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When substrate is added to the protein and the water molecule is displaced, the Fe(III)
center changes to a 5-coordinate high spin state (5cHS) with S = 5/2. This gives rise to a
signal with high rhombicity and g values that are usually centered at g ~ 8, 4 and 2. For
OleTSA the g values found are 7.89, 3.82 and 1.78; the rhombicity (E/D_ of the S = 5/2
signal is 0.092 and is highly similar to OleTJE (0.091) indicating a conservation of the
structural components of the heme in the 5cHS state.9
Together, UV-Vis and EPR spectroscopy suggest that the heme environment and geometry
within both proteins is very similar between the two enzymes. This may not be surprising
given that 95 % of the amino acids in the active site are retained. This similarity may be
important as the reactivity of P450s is highly can be highly sensitive to changes in heme
geometry and the local microenvironment.

Figure 3.4 EPR spectra of OleTSA. (A) OleTSA substrate-free (B) OleTSA eicosanoic acid
bound. Data was collected at a power of 2.5 mW and a modulation amplitude of 1 mT.
Temperature was maintained at 12 K.
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3.3 Binding of fatty acid substrates by OleT SA
The versatility of P450s can be explained by their ability to metabolize a large
number of substrates.23 This is especially important for the detoxification of drugs by
hepatic P450s in humans.24 In the CYP152 family of cytochrome P450s, this ability is
confined to predominantly linear acyl substrates due to the constraints enforced by the
binding pocket. Understanding the substrate scope in decarboxylases undoubtedly impacts
their biotechnological potential and will guide mutagenesis strategies to modify the binding
pocket of the protein to accept not only linear substrates but perhaps other substrates that
can be metabolized to other valuable commodity chemicals.
In OleTSA, the transition from a 6cLS to a 5cHS state upon substrate addition facilitates
determination of its dissociation constant (KD) using a Morrison quadratic equation that is
most accurate for tight binding substrates (Figure 3.5).

Figure 3.5 Binding of eicosanoic acid C20 to OleT SA. (A) UV-Vis spectra of subsequent
additions of C20 fatty acid. Black represents the initial spectra; red represents final spectra.
(B) Fitting of Δabsorbance at 418 nm versus fatty acid concentration. Black squares are the
actual data and red is the fitting.
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In OleTJE, longer chain length substrates induce a more pronounced degree of high spin
conversion than short chain fatty acids.25 This most likely derives from the increased
mobility of shorter substrates within the active site: longer substrates are more constrained
favoring one conformation that reinforces the dissociation of the water ligand, whereas
shorter substrates are more dynamic due to their restricted van der Waals contact with the
protein framework. This translates to an increase in the dissociation constant in short-chain
substrates.12 The same mechanism can be observed in OleTSA where eicosanoic (C20) or
stearic (C18) acid induce an increased 5cHS state with high affinities (Table 3.1). In
contrast to OleTJE, the change in affinity and 5cHS accumulation between substrates is less
pronounced, indicating a more restricted number of conformations adopted by shorter
substrates in the binding pocket. This is of great importance as we have previously
established that the decarboxylation process starts with hydrogen abstraction from the Cβ
position and requires exquisite positioning of the fatty acid within the active site.12-13
Additionally, it has been observed that the accumulation of the intermediates in OleT JE is
proportional to the initial amount of the 5cHS state. We anticipate the decreased dynamics
of the substrate in OleTSA favors decarboxylation of shorter chain length substrates and to
result in an equal, if not greater, accumulation of the relevant iron-oxo intermediates.
Table 3.1. Substrate affinity and 5cHS accumulation in OleTJE and OleTSA
Substrate
C20
C18
C16
C14
C12

OleTSA
K D Substrate
High-Spin
(μM)
Heme (%)
0.26 ± 0.50
90
0.32 ± 0.01
78
4.04 ± 2.41
73
2.48 ± 1.63
61
1.51 ± 0.05
71

95

OleTJE
K D Substrate
High-Spin
(μM)
Heme (%)
0.29 ± 0.05
90
0.20 ± 0.05
62
2.20 ± 0.12
31
7.5 ± 0.2
49
2.16 ± 0.70
49

3.4 OleTSA conserves β-regiospecificity and chemoselectivity
To ensure that the metabolic profile of OleTSA was retained, we performed a series
of steady state turnover experiments with a panel of saturated fatty acids (C20 through
C12). Initial comparison of the chemoselectivity in OleTSA and OleTJE is summarized in
Figure 3.6. As shown, exclusive decarboxylation is maintained with long-chain fatty acids
(C20 and C18) as expected. Shorter fatty acids (C16 through C12) produce higher amounts
of hydroxylated products, as is the case in OleTJE.9

Figure 3.6 Comparison of the chemoselectivity in OleTJE and OleTSA

Small differences can be observed however, with fatty acids C16 and C14, where OleTSA
seems to highly favor decarboxylation (88% of the product) in the former and produce
more hydroxylated product in the latter (54% of the product). A possible explanation for
this shift is the substitution of residue Leu176 in OleTJE to an isoleucine in the protein
studied (Figure 3.1). We have shown that small modifications of this residue can lead to
highly distorted chemoselectivity and would not be impossible for this residue to cause this
shift.12
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A closer look at the metabolic profile of OleTSA (Table 3.2) also reveals the conservation
of the β-regiospecificity. With the exception of myrstic acid (C14), the majority of the
alcohol products are predominantly oxidized at the Cβ position. As previously mentioned,
hydrogen abstraction at the β position is a requirement for ensuing decarboxylation.
Taking this into consideration, at least 90% of the substrate undergoes Cβ-H abstraction
for the panel of fatty acid substrates tested here. Previous studies have demonstrated
oxidation beyond the β-carbon, and in some cases, subsequent overoxidation of product
alcohol to a ketone in OleTJE.13, 26 No such products were detected in OleT SA, suggesting
that regardless the nature of the substrate, the acyl chain seems to favor no more than a few
conformations (α/β-oxidation; decarboxylation). This is further supported by the increased
accumulation of the 5cHS state even with short substrates.
Table 3.2. Full metabolic profile of OleTSA with a panel of different substrates.
Regioselectivity of the alcohol products is represented as percentage of the total
hydroxylated products. The C regiospecificity is defined as the fractional percentage of
alkenes and C alcohols over total products formed by the enzyme.
Substrate

Alcohol
(%)

Alkene
(%)

Conv.
(%)

100

C Regioselectivity
(%)
100

60

Product
accounting
(%)
83 ± 6

C20

0

C18

0

100

100

67.3

124 ± 16

C16

12.5
(3% α, 97% β)

77.5

99

85

117 ± 7

C14

46
(19% % 

54

90

100

96 ± 1

C12

13
(4% α, 96% β)

87

99

100

90 ± 11
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3.5 The overall crystal structure of OleTSA is conserved
Multiple turnover data have confirmed that OleTSA is a new decarboxylase member
from the CYP152 family of P450s. In recent years, much effort has been placed to
rationalize the unique chemistry of decarboxylases within this family.12-13, 25-27 Previous
crystallographic studies on OleT JE have attempted to highlight possible structural
differences between CYP152 decarboxylases and hydroxylases that may rationalize the
source of the divergent chemistries.9 Comparison of the active site of OleTJE and one of
the most studied hydroxylases of this family, P450 BSβ,11, 28-29 revealed an almost identical
active site with only minor substitutions. One of the most studied variations is residue
His85 which corresponds to a Gln in P450 BSβ (Figure 3.7).

Figure 3.7 Overlay of the active site of OleTJE and P450 BSβ. OleTJE is represented by the
purple structure; P450 BSβ is represented by the cyan trace. The heme from OleTJE is
represented in white.

98

Although there is no clear evidence for the role of this residue in decarboxylation, 25
mutagenesis studies in our group have shown that it is implicated in proper accumulation
of 5cHS state of the protein. Furthermore, rapid kinetic studies suggest this residue may
also be involved in the stabilization of compound II through hydrogen bonding. 15 Further
data analysis is required however, as glutamine can also serve as hydrogen bond donor,
although not as efficiently as a histidine.30 Finally, crystallographic data of OleTJE shows
a highly structured hydrogen bonding network in the substrate-bound form between a
solvent molecule and residues His85, Arg245 and the fatty acid substrate. This network
might be involved in the enhanced hydrogen peroxide activation in decarboxylases.
A second structural difference can be found between the F and G helixes. Decarboxylases
from this family have an extended FG loop that allows for proper constraint of the fatty
acid substrate.12 Through van der Waals interactions, Leu176 restraints the mobility of the
fatty acid tail. Although the hydrophobic nature of this residue seems to be conserved in
P450 BSβ (Val174),29 the shorter FG loop prevents this residue to come into contact with
the fatty acid, conveying a higher mobility to the substrate. In a recent study, we showed
the importance of this loop and leucine in decarboxylation. 12
The structural features described above were a requirement for this study as we wanted to
ensure that OleTSA is as similar as possible to OleTJE. To determine the crystal structure of
OleTSA, initial crystallization conditions were obtained using the high throughput (HT)
screening facility at the Hauptmann Woodward institute. The crystallization assays were
performed using the microbatch crystallization technique under 1536 different
conditions.17 From the HT screening only two conditions rendered positive hits (Figure
3.8A and B): condition A (0.5 M imidazole pH 7.5, PEG 3350 10% w/v) and condition B
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(0.1 M sodium molybdate, 0.1 M MES pH 6 and 20% w/v PEG 8000). Initial attempts to
reproduce crystals using the microbatch under oil crystallization technique in house were

Figure 3.8 Morphology of OleTSA crystals. (A) Initial condition from HT screening: 0.5 M
imidazole pH 7.5, 10% w/v PEG 3350 grown after 3 weeks. (B) Initial condition from HT
screening: 0.1 M Sodium Molybdate, 0.1 M MES pH 6; 20% w/v PEG 8000 grown after 3
weeks. (C) Optimized condition from cocktail A: 0.5 M imidazole, 10% w/v PEG 3350,
30% Al’s oil. Crystals grown after 1 week. (D) Optimized condition from cocktail B: 0.1
M Sodium Molybdate, 0.1 M HEPES pH 7.5, 20% w/v PEG 8000, 60% Al’s oil. Crystals
grown after 3 weeks. All the conditions were done using the hanging drop vapor diffusion
technique at 4 °C.
unsuccessful due to the lack of reproducibility of the drops. To optimize the conditions, we
attempted to crystallize the protein using the hanging drop vapor diffusion technique.
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Preliminary crystallization attempts delivered very fragile, poor-quality crystals. For
condition A, the use of 30% Al’s oil (1:1 silicon oil:paraffin oil) and cold conditions (4 °C)
was necessary to decrease the crystallization time and obtain single crystals. The initial
morphology provided by the HT screen showed clusters of needles. However, using
optimized conditions, single crystals in two morphologies were obtained. Figure 3.8C
shows both morphologies, one being cubic shaped and the other one similar to the one
obtained under the microbatch condition. Despite the quality of the crystal and the use of
several cryosolvents, no X-ray diffraction pattern could be obtained for any of the grown
crystals.
The second condition provided by the HT screening was proven to be more challenging to
reproduce (Figure 3.8B). Initial attempts using the provided cocktail did not produce any
crystal using either crystallization technique.
After several optimization rounds, crystals were grown after 3 weeks by substituting MES
for HEPES at pH 7.5 and using 60% Al’s oil to minimize nucleation. Figure 3.8D shows a
similar morphology of the crystal compared to the initial screen (Figure 3.8B). Single
crystals were soaked using mother liquor containing either 20 % glycerol or 20 % sucrose
(v:v) as a cryosolvent. X-ray diffraction patterns were obtained at SERCAT and the
structure was solved to 3 Å. Electron density analysis showed a highly disordered Cterminal domain as anticipated by the predicted structure. A lack of density for the last 8
amino acids of the protein was obvious. In an attempt to improve the resolution of the
structure, we deleted the last 8 amino acids and crystallized the protein in a similar manner.
Identical crystal morphology was obtained but the resolution was improved to up to 2.3 Å.
Structural parameters and refinement statistics are listed on Tables 3.3 and 3.4.
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Table 3.3. Data collection statistics
Data Collection
Statistics

OleTSA C20-bound

OleTSA mCPBA

Resolution Range (Å)

35.74 - 2.2

37.29 – 2.55

Space group
Unit cell (a/b/c; Å)
(α/β/γ; °)
Total reflections
Unique reflections
Multiplicity
Completeness (%)
Mean I/sigma (I)
Wilson B-factor (Å2)
Rmerge
Rmeas
Rpim
CC1/2
CC

C2221
69.3 93.7 186.2
90 90 90
209883 (17941)
31159 (3024)
6.7 (5.9)
99.5 (97.3)
8.2 (1.10)
37.7
0.143 (1.000)
0.155 (1.100)
0.0589 (0.4396)
0.996 (0.765)
0.999 (0.931)

C2221
67.7 94.0 183.7
90 90 90
168731 (12268)
19508 (1900)
8.6 (6.5)
99.8 (98.5)
11.6 (2.4)
32.42
0.142 (0.555)
0.151 (0.605)
0.05111 (0.2337)
0.997 (0.851)
0.999 (0.959)

Table 3.4. Structure refinement statistics
Structure Refinement
Statistics
Reflections used in
refinement
Reflections used for Rfree
R-work
R-free
Number of nonhydrogen atoms
Macromolecules
Ligands
Protein residues
RMS (Bonds; Å)
RMS (Angles; °)
Ramachandran favored
(%)
Ramachandran allowed
(%)
Ramachandran outliers
(%)

OleTSA C20-bound

OleTSA mCPBA

31122 (2992)

19503 (1899)

1289 (126)

1949 (190)

0.2551 (0.3351)
0.2927 (0.3876)

0.238 (0.226)
0.300 (0.306)

3474

3582

3409
65
419
0.009
1.12

3409
72
419
0.008
1.05

94.96

94.96

4.8

4.8

0.24

0.24
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Rotamer outliers (%)
Clashscore
Average B-factor (Å2)
Macromolecules
Ligands

5.19
11.16
42.17
42.23
39.42

5.74
17.71
30.77
30.56
31.4

An overlay of the substrate-bound structures of OleTSA and OleTJE (PDB code:
4L40) reveals the conservation of all the secondary structure components of the protein
including 11 α-helixes and 2-β sheets. The B-factors shown in Figure 3.9B reveal a
relatively rigid protein. The F and G helixes appear to have a higher B-factor, indicating a
higher flexibility compared to the rest of the protein. It is well known that these helixes are
flexible in P450s as they tend to undergo conformational changes to accommodate their
substrate.31-33 We hypothesize that, although these helixes are more flexible than the rest
of the protein, they should not undergo major conformational changes in decarboxylases
as the substrate is immobilized by residues in those regions.12-13 This is further supported
by the difficulty for these enzymes in metabolizing non-linear substrates.34-35 In addition
to this, the C-terminal domain of the protein appears to be less flexible as well. In contrast
to their hydroxylating orthologs, decarboxylases are able to metabolize long chain fatty
acids, suggesting the flexibility of the C-terminal domain of the protein to be involved in
the accommodation of longer substrates.
Analysis of the fatty acid binding pocket structure shows the overall conservation of the
features present in OleTJE, including most of the hydrophobic residues: Tyr24, Val75,
Leu79, Ile171, Ile174, Phe293, Val294 and Phe296.13 Figure 10A and 10B show the overall
structure of the FG loop located at the entrance of the binding pocket. The elongated loop
seems to be positioned in a similar manner as in OleTJE. The distance from the catalytic
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center to the residue involved in fatty acid anchoring is 17 Å apart as in OleT JE . Ile177 is
positioned 4.5 Å from the closest carbon of the acyl chain of the substrate. In OleT JE this
distance is shortened to 4 Å and the residue substituted by a leucine. Although both residues
have almost identical hydrophobic properties, the distance to the substrate might play an
important role in product release and chemoselectivity in OleT SA.

Figure 3.9 Crystal Structure of OleTSA. (A) Overlay of the crystal structure of OleTSA with
OleTJE (PDB: 4L40). In purple OleTSA and in white OleTJE. (B) Crystal structure of OleTSA
colored by B-factors: Blue represents lower B-factors and red higher B-factors.
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Figure 3.10 F-G loop structure comparison. (A) F-G loop in OleTSA with eicosanoic acid
bound. (B) F-G loop in OleTJE with eicosanoic acid bound.

Figure 3.11 Overlay of the hydrophobic cage in OleT SA and OleTJE

105

In OleTJE, residues Phe46, Phe297 and Leu176 serve as a “hydrophobic cage” for the
substrate, preventing the rattling of the fatty acid (Figure 3.11). Although there is no direct
evidence for the involvement of Phe46 in chemoselectivity, it would appear that this
residue would be important in stabilization of the substrate. In contrast, the substitution to
a threonine in OleTSA would indicate a possible change in the substrate preference to a
shorter-chain fatty acid and an increase in the mobility of the substrate leading to a higher
hydroxylation profile. Multiple turnover data demonstrates however, that chemoselectivity
with most of the fatty acid substrates is retained, undermining the importance of Thr48.
This residue may enable more facile release of the alkene. However, more detailed kinetic
and spectroscopic studies are needed to confirm this possible role.
Analysis of the structure of the catalytic center in OleTJE shows a highly structured
hydrogen bond network stabilized by Arg245, His85 and the fatty acid substrate. In OleTSA
this network seems to be less structured due to a change in the orientation of Arg247
(Figure 3.12). It appears that the N h1 atom of the guanidium group of the arginine is 1.5 Å

Figure 3.12 Active-site structure comparison. (A) Crystal structure of the active site in
OleTSA with eicosanoic acid bound. (B) Crystal structure of the active site in OleT JE with
eicosanoic acid bound (PDB 4L40)
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away from the O1 atom of the fatty acid Y-shaped terminus, putting it in direct hydrogenbonding distance. Additionally, the Nh2 of the guanidium group is 3.1 Å away from the O2
of the fatty acid substrate. In OleTJE, the distance between both oxygens of the fatty acid
substrate and the guanidium group is equal at 2.7 Å however, it hydrogen bonds to the Nh2
and Nε atoms.
The orientation of the arginine guanidium group in OleTSA is similar to what is observed
in the aromatic peroxygenase Aae-APO, suggesting that the precise binding orientation of
the fatty acid to Arg245 might be not be required for efficient hydrogen peroxide activation.
Additionally, it appears that His87 is 0.6 Å closer to the fatty acid compared to OleTJE.
Optical and EPR spectroscopy indicate very minor changes in the environment of the
protein, suggesting that the highly ordered H-bond network might not be favored in
solution.
3.6 Increased solubility of OleTSA establishes a new platform for high
concentration studies
We have demonstrated that the overall structure and reactivity of OleTSA is similar
to OleTJE. It is important, however, to determine the stability of the protein at high
concentrations as this is a requirement for advanced spectroscopy. A simple study to
answer this question was to evaluate the fraction of soluble protein in increasing
concentrations of precipitant. A study published by Kramer et al.21 evaluated the solubility
of seven different proteins in two different precipitants, PEG 8000 and ammonium sulfate.
Results of this research concluded that, while having very different properties, the nature
of the precipitant was irrelevant in the study of protein solubility. Given this result, we
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decided to base our study in the utilization of increased concentrations of ammonium
sulfate to a protein solution. We evaluated the amount of soluble protein using the heme
Soret band at 418 nm and the extinction coefficient ε418 nm = 112 mM-1cm-1. Briefly, to a
20 µM solution of P450 in 100 mM KPi pH 7.5, we added increasing amount of a saturated
solution of ammonium sulfate (4 M). Taking into account the dilution of the sample as we
add precipitant, we were able to determine predicted protein solubility in 100 mM KPi pH
7.5. Figure 3.13 shows the logarithm of the soluble fraction of the protein as a function of
ammonium sulfate concentration.

Figure 3.13 Solubility of decarboxylases in increased concentrations of ammonium sulfate
For each protein, the data shows an initial stationary phase where protein solubility
is unaffected by ammonium sulfate. For salts, this region corresponds to the salting-in
effect. As the concentration of precipitant is increased, the solubility of the protein
decreases and forms a linear decay phase corresponding to the salting-out effect.
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Equation 1

𝐿𝑜𝑔 𝑆 = 𝐿𝑜𝑔 𝑆𝑜 − 𝛽 [𝐴𝑚𝑚𝑜𝑛𝑖𝑢𝑚 𝑆𝑢𝑙𝑓𝑎𝑡𝑒]

This region can be fitted to equation 1 where So represents the solubility of protein in the
absence of ammonium sulfate and β represents the dependence of solubility of the protein
for ammonium sulfate. Projection of the fitting of the salting-out region to the y axis gives
the predicted protein solubility in the absence of precipitant. The β factor for OleTSA and
OleTJE was determined to be -0.94 M-1 and -0.81 M-1 respectively. Given the high
similarity of both proteins, the calculated β-factor was expected to be similar. The predicted
solubility for OleTSA was found to be an order of magnitude higher than OleTJE in 100
mM KPi pH 7.5. This is highly similar to our experimental observations, where aggregation

Figure 3.14 Surface electrostatics comparison between OleTJE and OleTSA. (A) and (B)
represent OleTJE in two different orientations. (C) and (D) represent OleT SA in two different
orientation. Electrostatic potential scale is found at the bottom.
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happens at concentrations above 150 µM. In contrast, no solubility problems have been
observed in OleTSA, even at concentrations higher than 1.5 mM. Solubility of proteins
have been correlated with an increase in the number of negatively charged residues in the
protein surface, presumably due to their ability to get into close contact with solvent
molecules.21 Surface electrostatics of both decarboxylases seem to be highly similar
(Figure 3.14). In addition to this, the predicted isoelectric point between both proteins
seems to be almost identical as well (5.2 for OleTSA and 5.7 for OleTJE). Either way,
rationalizing the dramatic improvement of solubility in OleTSA may require further
structural analysis of both proteins. This feature however, will be invaluable for the study
of the electronic properties of the catalytically relevant intermediates in decarboxylases.

3.7 Rapid kinetic spectroscopy shows the accumulation of the competent
intermediates in OleTSA
Cytochrome P450s are amongst nature’s most potent catalysts due to their ability
to activate inert C-H bonds.36 The use of a thiolate ligated heme as cofactor allows them to
produce powerful oxidants. Theoretical and experimental studies on inorganic complexes
suggest that these intermediates could possess redox potentials above 1 V.37 For a long
time, it was hypothesized that these enzymes utilize a ferryl-oxo pi cation radical heme
(compound I) as an intermediate for the activation of these inert bonds as suggested by
synthetic model compounds.38-40
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Scheme 3.1 Formation of compound I by the addition of meta-chloroperoxybenzoic acid
(mCPBA)

In 2011, Rittle and Green41 were able to capture and characterize the Compound I in the
thermostable P450 CYP119. The use of meta chloroperoxybenzoic acid allowed them to
obtain significant amounts of the intermediates through the reaction in scheme 1, where
mCPBA was added to the substrate-free enzyme. This technique bypasses the prototypical
catalytic P450 cycle by using the so-called “peroxide shunt”. Many attempts to reproduce
this technique have been done in other cytochrome P450s but have resulted in only the
meager accumulation of compound I.42-43 It is hypothesized that the presence of redox
active residues (Trp and Tyr) near the catalytic site is involved in the stability of this species
as it may easily oxidize the protein framework and lead to the rapid disappearance of
Compound I.44 The CYP152 family of P450s has naturally evolved to use hydrogen
peroxide as an oxygen and electron donor. 45 With the exception of P450 BM3,46 it is the
only family of cytochrome P450s that does not have an enzymatic redox partner.
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The ability of these enzymes to efficiently utilize hydrogen peroxide confers them the
ability to rapidly form intermediates. 14-15 Kinetic data of the rapid mixing of mCPBA
against these proteins, however, show very low efficiency in the accumulation of
intermediates but can slowly react with the enzyme (Figure 3.15). Crystallographic
structure of OleTSA substrate-bound soaked in 500 µM mCPBA shows that despite the poor

Figure 3.15 Photodiode array spectra of 20 µM OleTSA eicosanoic acid bound against 200
µM mCPBA. The slow reactivity of the enzyme with mCPBA doesn’t allow the
accumulation of compound I. Higher concentrations of mCPBA were used but rendered
the same result.

Figure 3.15 2FO-FC map of OleTSA substrate bound soaked with 500 µM mCPBA. (A)
represents the electron density with a contour level of 2 σ. (B) represents the electron
density with a contour level of 1.3 σ.
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accumulation of intermediates, the oxidant gets into the pocket and reacts to form metachlorobenzoate (Figure 3.16).
Previous work in our group has shown that OleTJE is the first P450 studied in which one is
able to prepare a significant amount of compound I in the presence of a substrate using the
native oxidant.14 Stopped-flow kinetic experiments revealed the accumulation of up 70%
of the compound I intermediate with a decay rate of ~80 s-1 in the presence of a
perdeuterated substrate. A significant kinetic isotope effect (KIE) on the decay rates of
compound I is observed when the enzyme is prepared with a protiated substrate (3.4) where
the decay rate approximates 300 s-1. (13 The KIE calculated suggested that decarboxylation
is initiated by hydrogen abstraction from the substrate, most likely at the Cβ, followed by
the formation a second intermediate that was later identified as a ferryl-hydroxy heme
(compound II).15 Further studies suggest that compound II abstracts a second electron from
the fatty acid radical through a proton-coupled electron transfer (PCET) process, forming

Scheme 3.2 Catalytic mechanism of decarboxylation in OleT JE
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a substrate carbocation which is rearranged to render the final decarboxylated product
(scheme 2). It has been shown that compound II is highly unstable in prototypical P450s
due to the tendency of the hydroxy group to bounce back to the substrate radical in a
process termed “oxygen rebound” producing a hydroxylated product. 47 Using norcarane
probes as radical clocks, it has been demonstrated that this intermediate is short-lived and
decays in no more than a few picoseconds.16, 47-49 Surprisingly, the decay rate of compound
II in OleTJE is lower than 10 s-1 implying that this intermediate is stable enough to last for
more than 100 miliseconds in the presence of the native substrate. 15 Furthermore, we have
shown that this intermediate is no less reactive than typical P450s as the use of norcarane
probes indicates very short lifetimes in the absence of native substrate. 16 It is clear,
however, that stabilizing this intermediate is essential to divert the oxygen rebound process
to the PCET to produce decarboxylated products. Understanding how these intermediates
are stabilized and their electronic properties will be informative of the mechanisms of
decarboxylation in the CYP152 family of P450s. The retention of reactivity and the
increase in stability of OleT SA at high concentrations will be useful in subsequent studies
of the reactive intermediates of decarboxylases. To ensure that proper accumulations and
decay rates remained untouched, we performed a series of stopped-flow experiments to
characterize the kinetics of the intermediates in OleT SA. Singular value decomposition
(SVD) of the data obtained from kinetic experiments on OleTJE allowed the determination
of the pure UV-Vis spectra of all the intermediates in the protein (Figure 3.17). 14-15 Using
the characteristic absorption of each intermediate we were able to similarly determine their
kinetics in OleTSA. Figure 3.16A and 3.16B show the photodiode array data obtained when
mixing 20 µM of OleTSA-C20 complex (ES) with 10 mM hydrogen peroxide. This was
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done in the presence of bound protiated or perdeuterated eicosanoic acid. Preliminary
examination of the data shows a complex reaction mechanism involving several
intermediates upon mixing. Very distinct traces are obtained from the differentially
isotopically labeled fatty acids. Pure spectra of the intermediates show that compound I has
a main Soret band centered at 370 nm and a minor charge transfer band at 690 nm arising
from the pi cation radical heme moiety. Analysis of the photodiode array data of OleT SA
(Figure 18A and 18B) shows a more dramatic accumulation of compound I in the presence
of deuterated substrate (d38) compared to protiated (h38). This is unsurprising as we have
established that compound I abstracts a hydrogen atom from the substrate via tunneling
event.14

Figure 3.16 Pure UV-Visible spectra of the catalytically relevant intermediates in OleTJE.
(A) Ferric 5-coordinate high spin (B) Ferryl-oxo pi cation radical heme (compound I) (C)
Ferryl-hydroxy heme (compound II) (D) Ferric 6-coordinate low spin
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SVD global analysis indicated the accumulation of ~ 65 % compound I with d38-C20 and
40 % with h38-C20 respectively. Although not far from the values obtained for OleTJE, the
latter appears to be slightly lower in the Staphylococcus ortholog. A possible explanation
for this phenomenon could be that the decay rate of compound II is similar to the decay
rate of the ferryl pi cation radical heme, preventing the high accumulation of the
intermediate.

Figure 3.18 Stopped-flow kinetic spectra of OleT SA. (A) Photodiode array trace of 10 µM
OleTSA bound to perdeuterated eicosanoic acid against 5 mM H2O2 (B) Photodiode array
trace of 10 µM OleTSA bound to protiated eicosanoic acid against 5 mM H2O2

To analyze the kinetics of this intermediate, the absorption at 370 nm was monitored as a
function of time. A multiphasic kinetic trace was obtained corresponding to compound I
decay, however, absorbance contribution from other intermediates might affect the exact
determination of the decay rates. To ensure that the kinetics of the intermediates were
reliable, we monitored the absorbance at 690 nm which, as previously mentioned, can only
arise from the pi-cation radical heme of compound I. A decay rate of 30 s-1 with d39-20
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and of 500 s-1 with h39-C20 was determined. The obtained KIEH/D was found to be 16.6;
this is a dramatic increase to what has been observed in OleT JE. The cause of this change
is not evident however, an enhanced hydrogen peroxide activation in OleT SA could be the
origin of this phenomenon. As we have previously described,14-15 an apparent
dissociation constant for hydrogen peroxide can be obtained by plotting the formation of
compound II as a function of hydrogen peroxide concentration.
For OleTJE this apparent KD was near 80 µM when protiated and deuterated substrates are
bound to the enzyme. In OleTSA there is no obvious accumulation of compound II in the
d38-C20 spectra (Figure 3.19A).

Figure 3.19 Single wavelength traces of the reaction of 10 µM OleT SA substrate-bound
against 5 mM H2O2. (A) Single wavelength trace at 440 nm of OleT SA bound to
perdeuterated eicosanoic acid (d39-C20). (B) Single wavelength trace at 440 nm of OleT SA
bound to protiated eicosanoic. (C) Single wavelength trace at 690 nm of OleTSA bound to
d39-C20. (D) Single wavelength trace at 690 nm of OleT SA bound to h39-C20.
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However, significant accumulation is observed with protiated substrate (Figure 3.19B).
SVD analysis determined the accumulation of compound II to be 50% with h38-C20.
Analysis of the formation rates as a function of hydrogen peroxide can be obtained by
monitoring the absorbance at 440 nm as previously described. Figure 3.20 confirms that
the apparent dissociation constant is at least 3-fold higher in OleTSA. A possible
explanation for this might be the unstructured hydrogen bond network in the active site as
shown by the crystal structure.

Figure 3.20 Hydrogen peroxide dependence in the formation of compound II

Further analysis of the absorbance at 440 nm indicate that compound II has a decay rate 53
s-1. The decay rate should be the same with deuterated substrate as compound II reactivity
is independent of the nature of the hydrogen isotope of the substrate. This decay rates
appear to be 5-fold higher than OleTJE but is still within the same order of magnitude,
suggesting a similar mechanism of stabilization of the intermediate to allow for the
decarboxylation of the substrate. Furthermore, the increased decay rate of this intermediate
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explains why the accumulation of compound II with perdeuterated substrate is not obvious,
as the decay rate of both intermediates is very similar (35 s-1 and 53 s-1). Taking all this
into consideration, we can conclude that despite having small kinetic differences, the
reactivity of the intermediates in OleT SA are similar than in OleTJE and can therefore be
used as a platform to study the fundamentals of their chemistry.

4. Conclusion
The biophysical and structural characterization of a new decarboxylase of the CYP152
family of P450 has been presented in this manuscript. UV-Vis and EPR spectroscopy
indicates that these two proteins have very similar heme environments including the second
coordination sphere. This is reflected on the similar reactivity of both proteins with a panel
of fatty acids which show that the decarboxylation features are retained. Furthermore, we
were able to crystallize and show that both proteins are structurally identical. More
importantly, we showed that OleTSA is an order of magnitude more stable than OleTJE, and
that it can properly accumulate the catalytically relevant intermediates observed in the
Jeotgalicoccus ortholog. Taking all this into account, OleTSA opens up a new platform for
the study of the electronic properties of the catalytically relevant intermediates in
decarboxylases from the CYP152 family of cytochrome P450s.
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CHAPTER 4
STOICHIOMETRIC PREPARATION AND REACTIVITY OF
COMPOUND I IN THE DECARBOXYLASE OLET-SA
Abstract
Cytochrome P450s are amongst nature’s most versatile catalysts. The thiolateligated heme cofactor has allowed these enzymes to become essential biological tools for
organisms to activate molecular oxygen and metabolize inert molecules. Previous P450
research has demonstrated how these enzymes can catalyze multiple chemistries on the
same types of substrate, ranging from simple epoxidations to decarboxylations. The origin
of this multiplicity can be attributed to the highly tunable nature of their heme-cofactor,
where small changes in heme environment and geometry can have large repercussions on
protein reactivity. In decarboxylases from the CYP152 family of P450s, the unusual
stability of the catalytically relevant ferryl-heme intermediates allows these enzymes to
redirect their chemistry from the P450 prototypical hydroxylation to the decarboxylation
of their fatty acid substrate. In this study, we discuss how small alterations of the heme
geometry in OleTSA translate to reactivity. Through a concerted effort of optical and EPR
spectroscopy, resonance Raman and crystallography we demonstrate how small alteration
in the distal pocket leads to a change in heme conformation, which at its turn, lead to a
change in the spin equilibrium of the protein and the reactivity of its ferryl-heme
intermediates.
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1. Introduction
Cytochrome P450s constitute a superfamily of proteins present in all kingdoms of
life.1 The functional diversity of their thiolate-ligated heme prosthetic group has allowed
these enzymes to become biological tools for organisms to activate molecular oxygen and
metabolize a plethora of substrates. These proteins catalyze a highly diverse set of difficult
reactions including but not limited to hydroxylations, epoxidations, nitrifications, and
decarboxylations, among many others.2-3 In humans, the versatility of these proteins is
exemplified by their ability to metabolize 75 % of exogenous molecules such as drugs and
other xenobiotics4, as well as their essential role in the metabolism of endogenous
molecules such as bile acids and steroids.5-7 Current and previous research on P450s has
focused on the elucidation of their mechanisms to chemically modify substrates, as they
have shown to be essential elements in almost all organisms. The understanding of the
chemistry of these enzymes has led to the development of therapeutic and biotechnological
tools that range from anti-cancer drug treatments in humans8 to their implementation in oil
biodegradation.9
Many cytochrome P450s can perform multiple types of chemistries on a single substrate.1011

Deciphering the multiplicity of the chemistry in these enzymes has become an important

focus of P450 research. In the last decade, this focus is highlighted in the elucidation of the
catalytic determinants for decarboxylation in the CYP152 family of P450s.12-15 This family
of proteins was initially functionally characterized as fatty acid hydroxylases.16-17 In 2011,
a member of this family, OleTJE, from the Jeotgalicoccus sp. bacteria, was shown to also
catalyze the decarboxylation of a fatty acid substrate to a terminal alkene and CO2.18
Previous research in our group has been highly focused on determining the features that
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give rise to decarboxylation in this family of enzymes. Using a panel of orthologs from this
family, we have been able to show the importance of substrate positioning in the
decarboxylation process.14 Furthermore, we have demonstrated the functionality of the
omnipresent F-G loop in maintaining the positioning of the substrate for proper
decarboxylation.13 Although much has been understood in the chemistry of these proteins,
there are still some ambiguous details regarding the molecular determinants for C-C bond
cleavage. Kinetic studies on OleTJE have revealed that the decarboxylation process
proceeds using the prototypical high-valent ferryl-heme intermediates of P450s (compound
I and compound II).19-20 Moreover, we have shown that the stabilization of compound II in
particular is necessary to allow a proton-coupled electron transfer (PCET) process between
this intermediate and a substrate radical, producing what is believed to be a transient
substrate carbocationic intermediate that allows for decarboxylation.20 It is evident that
understanding the unique ability of OleTJE to stabilize these intermediates is a major focal
point for establishing the mechanisms of decarboxylation.
The optical properties of the heme cofactor in cytochrome P450s facilitate their study using
optical spectroscopy.21 While much information can be derived regarding the redox state
of the heme and its environment, advanced spectroscopies such as electron paramagnetic
resonance (EPR) and Mössbauer are necessary to further understand the electronic
properties of the prosthetic group, particularly for transient reaction intermediates. These
techniques however, require preparations that require a high concentration of protein and
substrate and to obtain an intermediate in the purest form possible. Given the hydrophobic
nature of both the substrate and protein, decarboxylases from the CYP152 family often
tend to be poorly soluble and aggregate at higher concentrations. We have addressed this
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limitation in chapter 3 of this dissertation through the characterization of OleTSA, a new
member of this family from Staphylococcus aureus. OleTSA possesses the same metabolic
profile as OleTJE but is at least an order of magnitude more soluble. Moreover, we have
revealed the importance of the initial spin state of the heme cofactor for accumulation of
the transient intermediates in decarboxylases. We established that in order to attain
maximal accumulation of compound I and compound II, OleT SA needs to be in the 5coordinate high spin state (5cHS) to efficiently activate the native H2O2 oxidant and yield
Compound I. To slow down the reactivity of Compound I, however, low temperatures are
required. Notably, the 6-coordinate low spin (6cHS) to 5cHS spin-state transition is
disfavored under these conditions. In this study, we characterize a mutation on the axial
side of the heme cofactor (“cys-pocket”) in OleTSA that alters the spin-state equilibrium of
the protein, allowing for the stoichiometric accumulation of Compound I at extremely high
concentrations. Through multiple spectroscopies and crystallographic studies, we
demonstrate that the origin of this alteration in spin-equilibrium is a distortion in the heme
planarity that is caused from altering an alanine to a bulkier proline residue. This research
establishes a platform to understand the mechanisms of transient intermediate stabilization
in decarboxylases from the CYP152 family, and more generally the cytochrome P450
reaction coordinate, at a level of detail that has been unattainable to date.
2. Experimental Procedures

2.1 Reagents and chemicals
All buffers used in this study were purchased from BDH chemicals. Hydrogen
peroxide and sodium dithionite were purchased from Sigma Aldrich. Eicosanoic
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(C20H40O2), octadecanoic (C18H36O2), hexadecanoic (C16H32O2), dodecanoic (C12H24O2),
were purchased from Supelco Analytical. Deuterated fatty acids were purchased from CDN
Isotopes. P450 BSβ was a generous gift from Dr. Michael T. Green.

2.2 Mutagenesis of P450 BSβ and OleTSA
The point mutation glutamine to histidine at position 85 in P450 BSβ was generated
by PCR using the following primer and its reverse complement with the mutated codon
underlined:
5’ GGTGTTAATGCAATTCACGGTATGGATGGTAGC 3’
The point mutation of proline to alanine at position 364 in P450 BSβ was generated by
PCR using the following primers with the mutated codon underlined and using either wildtype or BSβ_Q85H as a template:
5’ TTGTGCGGGTGAAGGTATTACCATTGAAGTGA 3’ Fwd
5’ CACCCGCACAACGATGACCTTTTTCTGCATGAC 3’ Rev
The point mutation alanine to proline at position 369 in OleTSA was generated by PCR
using the following primers with the mutated codon underlined:
5’ GTTGCCCTGGCGAGTGGATGACCATTATCATTATG 3’ Fwd
5’ GCCAGGGCAACGATGGTTGGTATAGTAGTCACCAC 3’ Rev
Following PCR, plasmids were digested by DpnI for 1 hour at 37 °C to remove the parental
plasmid. Following digestion, plasmids were transformed into Escherichia coli XL1 Blue.
Resulting mutations were verified by sequencing at EtonBio Inc. (North Carolina).
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2.3 Expression and purification of OleTSA and its variant
Expression and purification of both OleT SA wild-type and A369P were identical to
the protocol previously described in Chapter 3. The final yields for both proteins were 80
mg of protein per liter of culture. The R Z ratio (A418/A280) was greater than 1.2, indicating
a high degree of purity and heme incorporation into both variants.

2.4 Expression and purification of P450 BSβ and its variants
Expression of P450 BSβ wild-type, Q85H and Q85H/A366P was done in a similar
manner as OleTSA. Briefly, the plasmids were transformed onto BL21(DE3) containing the
pTF2 plasmid encoding for GroEL/GroES/Tig onto a kanamycin/chloramphenicol LB
plate. One colony was inoculated into 150 mL of modified Terrific Broth (12 g yeast
extract, 6 g tryptone, 2 g peptone) supplemented with 50 µg/mL kanamycin and 20 µg/mL
chloramphenicol and grown overnight at 37 °C. 10 mL of starter culture were inoculated
into 500 mL of modified terrific broth containing 50 µg/mL kanamycin, 20 µg/mL
chloramphenicol, 125 mg/L thiamine and trace metals. The culture was initially grown for
~2 hours at 37 °C until OD600nm = 0.8, at which point the temperature was decreased to 18
°C until the OD600nm reached 1.5. At this point, cultures were induced with 100 µM IPTG,
10 ng/mL tetracycline and 10 mg/L of 5-aminolevulinic acid and grown for an additional
15 hours at 18 °C. The following day, cultures were centrifuged 10 minutes at 6000 rpm
and the pellet was resuspended in 4 mL of Buffer A (50 mM KPi pH 8, 300 mM NaCl and
10 mM imidazole) per gram of pellet. Cells were disrupted using a Branson sonifier and
stirred for an hour before centrifuging 30 minutes at 16,000 rpm. The supernatant was
loaded onto a previously equilibrated Ni-NTA column, washed with buffer A + 25 mM
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imidazole and eluted with buffer A + 250 mM imidazole. The eluate was diluted 1:1 with
Buffer B (50 mM KPi pH 8, 300 mM NaCl 60% ammonium sulfate) to reach a final
concentration of 30% ammonium sulfate. The diluted protein was then loaded onto a
previously equilibrated Butyl-S-Sepharose column, washed with 10 column volumes of
Buffer C (50 mM KPi pH 8, 300 mM NaCl and 30% ammonium sulfate) and eluted with
a gradient over 8 column volumes from buffer C to buffer D (50 mM KPi pH 8). Fractions
with a 418nm/280nm ratio higher than 1.3 were pooled and dialyzed against 50 mM KPi pH
8 200 mM NaCl. Proteins were concentrated to 200 µM, flash frozen in liquid nitrogen and
stored at -80 °C until further use. Final yields for all three variants were similar at around
65 mg of protein per liter of culture. The theoretical R Z ratio is 1.6 and is not far from what
was obtained, indicating a highly pure protein preparation.

2.3 Spectroscopy
a) UV-visible
UV-visible spectra were obtained using an Agilent HP 8453 spectrophotometer. 10
µM of protein in 200 mM potassium phosphate (KH2PO4) pH 7.5 was used to titrate fatty
acids dissolved in 70% ethanol: 30% Triton X-100 (v:v). The amount of ethanol added
never exceeded 5% of the total volume. Dissociation constants were determined by plotting
the change in absorbance at 418 nm and 396 nm and fitting them into the Morrison equation
for tight binding as previously described.15 All the absorbance changes can be attributed to
the fatty acid binding as titrations with pure Triton X-100 did not induce any spin change.
The ferrous forms of the protein were prepared by the addition of 50 µM of sodium
dithionite to a solution of 10 µM P450 supplemented with 500 nM methyl viologen under
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anaerobic conditions. The carbonmonoxy adduct was prepared by bubbling carbon
monoxide for thirty seconds to the ferrous for of the protein.
b) EPR spectroscopy
EPR spectroscopy was performed as previously described (chapter 3). All the
substrate-free forms of the proteins were prepared by the addition of 15 molar equivalents
of hydrogen peroxide and incubation for 30 minutes prior to treatment with Biobeads SM2 to remove any adventitiously bound hydrophobic molecules. After treatment, the protein
was desalted in 200 mM potassium phosphate (KH2PO4) pH 7.5 using a PD-10 desalting
column to remove any excess hydrogen peroxide. All the substrate-bound forms contained
1 molar equivalent of the indicated fatty acid dissolved in 70% ethanol:30% Triton X-100
(v:v). Final protein concentrations were 200 µM. All the samples were flash-frozen and
kept at liquid nitrogen temperatures until further use. EPR spectra were recorded on a Xband Bruker EMXplus spectrometer equipped with an Oxford Instruments liquid helium
continuous flow cryostat. Spectra were recorded at a temperature of 15 K, a power of 2
mW and an amplitude of 1 mT.
c) Magnetic Circular Dichroism (MCD) spectroscopy
Substrate-free and C20 fatty acid bound OleTSA samples were prepared as
described above, using 10 µM enzyme. Ferrous carbonmonoxy P450 adducts were
prepared by combining 10 µM OleTSA (substrate-free or C20-bound) with 500 nM methyl
viologen. The solution was made anaerobic by purging with N 2 gas. Carbon monoxide gas
was bubbled into the solution, and the protein was reduced to the ferrous state with sodium
dithionite. MCD spectra were obtained on a Jasco J-815 CD spectrometer with a 1.4-Tesla
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electromagnet. The sample was maintained at 3 ºC using a Lauda-Brinkmann RM6
recirculating water bath.
d) Resonance Raman Spectroscopy
Resonance Raman studies on OleTSA was performed by Dr. Yilin Liu and Prof.
James Kincaid at Marquette University. The following experimental procedures were used.
All proteins were centrifuged to remove any precipitation before measurements. The ferric
proteins were diluted to 100 µM with 200mM KPi pH 7.5 and transferred to NMR tubes
for measurements. Two molar equivalents of hydrogen peroxide were added to the
substrate-free sample to keep protein in the low spin state. To prepare the ferrous CO
adducts, 70 µL of 150 µM proteins (wild-type OleTSA, theA369P mutant, and their
substrate-bound forms) were transferred into NMR tubes (WG-5 Economy, Wilmad),
respectively, sealed with a rubber septum. The ferrous CO complexes were prepared by
saturation the sample with CO gas prior to the injection of excess sodium dithionite
solution.
The spectra of ferric samples were obtained using 406.7 nm excitation line, which was
provided by a Kr+ laser (Coherent Innova Sabre Ion Laser) with a Spex 1269 spectrometer
equipped with a Spec-10 LN liquid nitrogen cooler detector (Princeton Instruments). The
spectra of ferrous CO complexes were measured using 441.6 nm excitation line from a HeCd laser (IK series He-Cd laser, Kimmon Koha Co., Ltd). The slit width was 150 μm for
all the measurements except for high-frequency measurement on ferrous CO samples,
where it was increased to 250 µm facilitating detection of the weaker intensity ν(C-O)
modes. The laser power for ferric and ferrous samples was kept around 13mW, whereas
spectra of the ferrous CO complexes were obtained using ~1 mW to avoid
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photodissociation. All samples were measured in spinning NMR tubes, where a cylindrical
focusing lens was used to avoid local heating and protein degradation. Spectra were
calibrated with fenchone and acetone-d6 (for calibration with high frequency above 1700
cm-1), and processed with Grams AI software. It is important to note that the substratebound CO samples precipitated after 20-30 minutes during measurement under a 1 mW
laser power, showing low signal/noise ratios in the CO region.

2.4 Temperature-dependent UV-visible spectroscopy and analysis
Experiments were performed by Olivia Manley and the following experimental
methods are credited to her. Substrate-free OleTSA (WT or A369P) was prepared by
incubating 10 µM of the as-purified enzyme with 3 molar equivalents of H2O2 to turn over
adventitiously bound fatty acids. The enzyme-substrate complex was prepared by
incubating 10 µM of the as-purified enzyme with 3 molar equivalents of the desired fatty
acid at 4 °C for at least 4 hours to allow for complete fatty acid binding. The absorbance
spectra of the samples were obtained at various temperatures using a Cary 400 Bio UVvisible spectrophotometer equipped with a PolyScience circulating water bath. The
pyridine hemochromogen assay22 was used to determine the extinction coefficients of the
Soret peak of pure HS and LS samples (ε394 = 106.5 mM-1 s-1 and ε418 = 56.6 mM-1 s-1 for
HS; ε394 = 62.5 mM-1 s-1, ε418 = 112.8 mM-1 s-1 for LS; and ε406 = 86.8 mM-1 s-1 for both
HS and LS as 406 nm corresponds to the isosbestic point). In a similar manner to the
analysis of P450cam by Sligar,23 these extinction coefficients were used to calculate the
fraction of the enzyme in the HS and the LS states for each sample. The equilibrium
constants were determined by K = [HS]/[LS] for each sample and were modeled to an
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Arrhenius temperature dependence to produce a linear van't Hoff plot, from which the
enthalpy and entropy of the equilibrium constants were determined. For T = 20 °C, the
Gibb's free energy and the equilibrium constant representative of the spin shift equilibrium
(Kspin) were calculated.

2.5 Crystallography
a) Sample preparation
A solution of OleTSA A369P with a RZ ratio of 1.3 was treated with 2 molar
equivalents of eicosanoic acid and incubated for 2 hours at 4 °C. The protein was
subsequently buffer-exchanged in 200 mM KPi pH 7.5 with a PD-10 desalting column and
treated for 2 hours at 4 °C with Biobeads SM-2 to remove any remaining fatty acid and
Triton X-100. The protein was finally concentrated to 600 µM (~30 mg/mL) and flash
frozen in liquid nitrogen until further use.
b) Crystallization conditions
Crystals were grown in a similar manner as the wild-type enzyme (chapter 3).
Briefly, 1 µL of protein was diluted with 1 µL of mother liquor (100 mM HEPES pH 7.5;
100 mM sodium molybdate; 20 % PEG 8000) in a total volume of 2 µL. Hanging-drop
trays were incubated at 4 °C for three weeks for optimum crystal growth. Crystals were
harvested and soaked in mother liquor supplemented with 20 % glycerol as a cryoprotectant
and cryo-cooled in liquid nitrogen.
c) Data collection and processing
Data collection was performed at the Advanced Photon Source (Lemont, Il, USA),
beamline 22-ID, through the Southeast Regional Collaborative Access Team (SER-CAT).
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Integration and scaling of the data was done using the HKL-2000 software package.24
Structure phasing was done by molecular replacement using the substrate-bound OleTSA
structure as an initial model (described in chapter 3) in the Phenix Phaser program.25 Model
building was done by using the original wild-type enzyme as a scaffold using WinCoot.26
Final refinement and validation was done through Phenix Refine and Phenix Validate
respectively.25 All the figures were generated using Pymol Molecular Graphics software
package (Version 1.3 Schrödinger LLC).
Heme out-of-plane distortion values were determined using the Normal-Coordinate
Structure Decomposition software developed by Shelnutt. 27

2.6 Stopped-flow kinetics
To prepare OleTSA for stopped-flow experiments, adventitiously bound FAs were
removed by treating the protein with 15 molar equivalents of H2O2, and the protein was
subsequently desalted into 200 mM KPi at pH 7.5. All proteins were then concentrated to
~200 µM and diluted in 200 mM KPi at pH 7.5 to a final concentration of 20 µM. Proteins
were then incubated with two molar equivalents of FA substrate from and incubated at 4
°C for at least 4 hours to allow fatty acid binding; ethanol concentration did not exceed 5%
of the total volume. A stock of 10 mM H2O2 was prepared in 200 mM KPi at pH 7.5 and
incubated at 4 °C prior to use. Stopped-flow experiments were carried out on an Applied
Photophysics Ltd. SX20 stopped-flow spectrophotometer. Briefly, each protein stock was
rapidly mixed 1:1 against 10 mM H2O2 for a final concentration of 10 µM protein and 5
mM H2O2 post-mix. Single wavelength traces were collected using a photomultiplier tube
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and full spectrum data using a photodiode array. Data processing was done as previously
described (chapter 3).

3. Results
Kinetic studies in our lab have allowed us to establish the overall catalytic
mechanism for decarboxylation in OleT.19-20, 28 Scheme 1 shows a compilation of the
general reaction sequence for decarboxylation. The initial state of the protein involves a
water molecule as a sixth ligand of the heme, in what is termed the 6-coordinate low-spin
state (6cLS). Upon substrate binding, the water molecule is displaced and the heme
undergoes a transition to a 5-coordinate high spin state (5cHS). When hydrogen peroxide
is rapidly mixed to the enzyme-substrate complex, OleT SA forms the initial transient
intermediate compound I. This ferryl pi-cation radical heme is a powerful oxidant that

Scheme 4.1 Decarboxylation mechanism in OleT SA with protiated eicosanoic acid bound
with observed kinetic rate constants derived from transient absorption studies.
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proceeds to abstract a hydrogen from the β-carbon of the fatty acid to form a substrate
radical and compound II. The protonated ferryl-heme is then involved in a proton-coupled
electron transfer (PCET) between this intermediate and the substrate radical to render the
final decarboxylated product. The atypically low decay rate constants for both
intermediates has allowed their detailed kinetic characterization. Their unusual stability is
a hallmark for their involvement in the decarboxylation process in CYP152 enzymes.
Further studies on these intermediates however, has been hampered by the
strenuous conditions required for rapid freeze-quench methods for their capture. In order
to maximize their accumulation, it is imperative for the protein to be in the 5cHS state
before rapidly mixing with hydrogen peroxide. This feat is practically complex as it
requires the solubilization of long chain fatty acids and a promotion of spin-state
conversion despite the low temperatures necessary for intermediate stability. A possible
route to circumvent this problem would be to disrupt the spin-state equilibrium (Kspin) to
favor the 5cHS state. Previous studies have shown that changes in the heme environment
can lead to alterations in the Kspin in other P450s.29-30 A clear example of this type of
alteration has been observed in P450coh where the placement of hydrophobic residues on
the distal pocket results in an increased accumulation of the 5cHS state. 30 These residue
changes however, were also shown to affect substrate selectivity and thus the final
metabolized product.
In CYP152 enzymes, alterations of an active site histidine (H87 in OleTSA) have
been shown to affect high-spin accumulation. Mutagenic conversion of His85 in OleT JE to
a glutamine residue (reminiscent of hydroxylases from this family; Figure 4.1A) resulted
in a lower accumulation of the 5cHS even in the presence of substrate.12 Preliminary data
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in our group showed that the analogous mutation (glutamine to histidine) in the P450 BSβ
hydroxylase results in an increased accumulation of the 5cHS state of the protein (Figure
4.4.1B) supporting the involvement of this residue in maintaining spin-state equilibrium.

Figure 4.1 Effect of the mutation of residue 85 in P450 BSβ hydroxylase. (A) Crystal
structure of OleTSA and P450 BSβ. In purple OleT SA and in cyan P450 BSβ. (B) UV-Vis
spectroscopy of the maximal 5cHS accumulation in P450 BSβ wild type (red) and P450
BSβ Q85H.

Although mutagenesis data suggest that changes in the distal heme environment might be
effective in modulating the Kspin in these enzymes, this is not the most efficient approach.
The high dependence of the decarboxylation process on substrate positioning limits this
strategy as any disruption could lead to the hydroxylation of the substrate and the loss of
intermediate stabilization.
Another approach to alter the Kspin is to alter the hydrogen bonding environment of
the Fe-S bond. In a recent study by Krest et al,31 the authors described the importance of
the H-bonding network on the “cys-pocket” for regulating P450 reactivity. They
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demonstrated that a weaker hydrogen bonding network leads to a shorter Fe-S bond length
which in turn leads to greater reactivity in P450s compared to chloroperoxidases. Extensive
research has also been done on CYP2B4 where the change of a phenylalanine residue to a
histidine on the proximal side of the heme leads to changes in the redox potential and other
properties of the protein.32-33 Although there is no direct evidence that the H-bonding
network is specifically involved in modulation of the spin-state equilibrium, it is clear that
subtle changes might affect it.
Hydroxylases from the CYP152 family, like P450 BSβ and P450 SPα, possess a
proline residue that is adjacent to the cysteine ligand, whereas decarboxylases often possess
an alanine residue. The crystal structure of these proteins shows a change in the hydrogen
bonding network of the Fe-S bond (Figure 4.2), with decarboxylases having an additional
hydrogen bond to the thiol which would translate to weaker reactivity. The strong
differences in 5cHS accumulation between hydroxylases and decarboxylases remains

Figure 4.2 Crystal structure of the “cys-pocket” H-bonding network in OleTSA and P450
BSβ. (A) OleTSA; 3 hydrogen bonds are shown to the Fe-S stretch coming from residues
A369, G370 and Q357. (B) P450 BSβ (PDB code: 1IZO); 2 hydrogen bonds are shown to
the Fe-S stretch coming from residues G367 and Q352.
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highly uncharted. It is clear however, that these types of interactions might somehow be
involved in the spin equilibrium of CYP152 enzymes. To explore the effects of such
changes, we studied the effects of the mutation OleT SA A369P and P450 BSβ P366A.

3.1 The proline to alanine mutation of residue 366 in P450 BSβ disrupts the
spin equilibrium favoring the 6cLS state
As shown in Figure 4.1B, wild-type P450 BSβ can only accumulate 42% 5cHS
even in the presence of an excess of the native substrate hexadecanoic acid. In OleTSA the
accumulation of the 5cHS form with its corresponding native substrate (presumed to be
eicosanoic acid such as in OleTJE) is at least 2-fold larger than for BSβ. Given the high
similarity of the active of both enzymes, this suggests that modulation of the spin
equilibrium is done by single residues near the heme. To understand the effects of Pro366
in 5cHS accumulation, we mutated this residue to the alanine found in the decarboxylases
of this family. We anticipated that if this residue is involved in spin-equilibrium it would

Figure 4.3 UV-Vis absorption spectra of P450 BSβ mutants. (A) P450 BSβ_P366A; black
represents the substrate-free form and red in the presence of excess hexadecanoic acid. (B)
P450 BSβ_Q85H/P366A; black represents the substrate free form and red in the presence
of excess hexadecanoic acid.
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favor the 5cHS state like in OleT SA and OleTJE. Since it has already been shown that residue
Gln85 in P450 BSβ is involved in the spin transition, we also produced the double mutant
Q85H/P366A to discard any involvement of the glutamine in the process. Figure 4.3 shows
the UV-Vis spectra of both mutants in their substrate-free form and in the presence of
excess hexadecanoic acid.
As is evident from the spectra, the 5cHS accumulation, which is monitored by an increase
in the absorbance at 394 nm, is highly affected by the proline to alanine change. In the
substrate-free form, both the single and double mutant show a maximum Soret absorbance
at 418 nm, consistent with a water molecule as a 6th ligand to the Fe(III) center. Upon
substrate addition, a small spin transition can be observed in the single mutant to a final
5cHS accumulation of 23 %. This is a 20% decrease to what is observed in the wild-type
enzyme (Figure 4.1B). A similar change can be observed in the double mutant in which
the maximal 5cHS accumulation is 41 %. This is again a 20 % decrease to what is observed
for the single Q85H mutant.

Table 4.1 Maximal 5cHS accumulation for P450 BSβ and OleT SA and all their variants
determined at 20 °C.
% 5-coordinate high spin accumulation
Substrate

P450 BSβ

P450 BSβ
Q85H

P450 BSβ
P366A

P450 BSβ
Q85H/P366A

OleTSA

OleTSA
A369P

C20
C16
C12

ND*
42
40

ND*
64
55

ND*
23
15

ND*
41
40

90
73
71

100
95
90

* not detected
Similar trends are obtained with other fatty acid substrates (Table 4.1), supporting the
notion of the involvement of this residue in modulating Kspin. Although still unclear how
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these mutations affect the Kspin of the protein, the data suggests that the analogous mutation
in decarboxylases would favor the 5cHS accumulation. To our knowledge, such effects
have never been observed in other P450s. Further studies on the engagement of this residue
in spin transition is necessary.

3.2 Alanine to proline change of residue 369 in OleTSA highly favors the 5cHS
state of the protein
To further examine the involvement of residue 369 in decarboxylases, we mutated
Ala369 in OleTSA to a proline and examined its high spin accumulation. Figure 4.4 shows
the UV-Vis spectra of the mutant in both the ferric and ferrous state, as well as its carbonmonoxy ferrous form. The 5cHS accumulations with different fatty acids are compiled in
table 4.1

Figure 4.4 UV-Vis spectra of OleT SA A369P. (A) Ferric spectra; black represents the
enzyme in the substrate-free form, black dashed line represents the enzyme in the “aspurified” form and red represents the enzyme with an excess of eicosanoic acid. (B) Ferrous
spectra; black represents the enzyme in the ferrous form and red the carbon monoxy ferrous
enzyme.
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Initial examination of the spectra of the as purified protein (Figure 4.4A, black dashed line),
indicates that 90 % of the protein is purified in the 5cHS state. This phenomenon has also
been seen in the wild-type enzyme due to the presence of adventitiously bound fatty acids
from E. coli, predominantly C16, although to a much lesser extent (chapter 3). This could
be due to the presence of a larger amount of fatty acid in the protein preparation, which
seems unlikely, a shift of the spin-state equilibrium or a change in the dissociation constant
(KD) of the enzyme for its substrate. Addition of hydrogen peroxide to remove any bound
substrate induces the full transition to a 6cLS state with a water bound as a 6 th ligand in
CYP152 enzymes. The OleTSA A369P mutant shows however, the presence of 20% 5cHS
even in high excess of hydrogen peroxide (Figure 4.4A, black line). This is highly
indicative of a change in the heme environment favoring the 5cHS state even in the absence
of substrate. Addition of eicosanoic acid in excess fully drives the protein to the 5cHS
compared to wild-type where 90% is observed. Although this change is subtle, the low
temperatures required for the rapid freeze-quench conditions are expected to decrease the
high spin accumulations by about 20% in both proteins due to the temperature dependence
of spin conversion, in which case this subtle change will become important. The
thermodynamic behavior of the spin transition is addressed in the following section.
The transition observed with other fatty acid substrates highly indicates that the enzyme
now favors the 5cHS both in the substrate-free and substrate-bound form. A possibility of
the higher accumulation can be explained by an increased affinity of the enzyme for fatty
acids. Given the fact that we have not changed any residue involving fatty acid binding and
that the substrate does not directly ligate to the Fe(III) center, it seems highly unlikely that
this would be the case. Table 4.2 shows the dissociation constants determined from the
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absorbance change at 418 nm and their fitting using the Morrison equation for tight
binding. This data shows very minimal changes in the KD of the wild-type enzyme and the
mutant, demonstrating that the affinity remains unaffected.
Table 4.2 Dissociation constants of a panel of fatty acids for OleT SA wild-type and OleTSA
A369P.
Fold
K D (µM)
change
from WT
Substrate

Wild-Type

A369P

C20
C18
C16
C14
C12

0.26 ± 0.52
0.32 ± 0.01
4.04 ± 2.41
2.48 ± 1.63
1.51 ± 0.05

0.34 ± 0.02
0.24 ± 0.01
1.49 ± 0.02
1.24 ± 0.02
1.21 ± 0.02

1.31
0.75
0.36
0.5
0.8

To ensure that the thiolate ligated heme moiety has been preserved in the mutant, we
prepared the carbon-monoxy ferrous complex which shows maximal accumulation at 443
nm, confirming the preservation protein integrity (Figure 4.4B). This data demonstrates
that residue 369 is involved in the accumulation of the 5cHS of the heme in CYP152
enzymes and goes in accordance to what was observed in the analog P450 BSβ mutation.
Understanding the thermodynamic parameters and origin of this alteration is essential for
its implementation in high resolution spectroscopy.

3.3 The spin equilibrium K spin is highly altered in OleTSA_A369P
In cytochrome P450 chemistry, the equilibrium constant Kspin is defined as the ratio
of the 5cHS fraction over the 6cLS fraction determined from the absorbances at 394 nm
and 418 nm respectively. Unlike the dissociation constant of fatty acids (KD), the
equilibrium constant Kspin gives information about the spin equilibrium of the system
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irrespective of the presence of substrate. Hence, it can provide valuable information on
which spin conformation is favored on a specific P450 at given conditions. This
equilibrium constant gives information about which spin conformation is favored at certain
conditions. In most P450s, Kspin has a high temperature dependence originating from pure

Figure 4.5 High-spin temperature dependence. (A) UV-Vis spectra of OleTSA wild type as
a function of temperature in the presence of dodecanoic acid. Black line represents the
protein at 4 °C and red represents the protein at 20 °C. (B) UV-Vis spectra of
OleTSA_A369P wild type as a function of temperature in the presence of dodecanoic acid.
Black line represents the protein at 4 °C and red represents the protein at 20 °C. (C) Van’t
Hoff plot derived from the temperature dependence of the equilibrium constant of OleT SA
in the presence of dodecanoic acid. (D) Van’t Hoff plot derived from the temperature
dependence of the equilibrium constant of OleT SA_A369P in the presence of dodecanoic
acid.
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electronic rearrangements of the heme as well as global structural changes from the protein
and substrate.34 The generation of van’t Hoff plots from Kspin as a function of temperature
is necessary to derive thermodynamic parameters of the spin transition and are specific for
each cytochrome P450.
Spectroscopic data indicates that the A369P mutation in OleT SA highly affects the 5cHS
accumulation at room temperature. Dissociation constant determination from different
fatty acids indicate that there is no significant change in the KD of the mutant compared to
the wild-type, indicating that the affinity has remained unaffected in the mutant and that
the Kspin change is most likely coming from a change in the heme properties. To compare
the thermodynamic parameters of this spin transition between both proteins, we calculated
Kspin at different temperatures and generated the corresponding van’t Hoff plots.23

Table 4.3 Thermodynamic parameters for OleT SA and A369P with C20 and C12 fatty
acids. Kspin and ΔG values were calculated at 20 °C.
Protein

Substrate

Kspin

ΔG (kcal.mol-1)

ΔH
(cal.mol-1)

ΔS (cal.mol1.K -1)

OleTSA

C20
C12

4.8 ± 0.9 x 107
3.65 ± 0.09 x 103
6.15 ± 0.30 x 103

10.0 ± 2.0
4.8 ± 0.1
5.1 ± 0.2

23.0 ± 3.0
8.2 ± 0.2
10.0 ± 0.3

35.2 ± 0.5
16.3 ± 0.3
17.4 ± 0.6

-

1.6 ± 0.2 x 108

11.0 ± 1.0

24.0 ± 2.0

38.0 ± 0.4

C20
C12

7.15 ± 0.28 x 108
4.28 ± 0.13 x 104

11.9 ± 0.5
6.2 ± 0.2

18.4 ± 0.6
9.85 ± 0.20

40.5 ± 1.0
21.2 ± 0.4

OleTSA
A369P

Figure 4.5 A and B show a representative UV-Vis spectrum of both the wild-type and
A369P enzyme in the presence of a short-chain fatty acid (dodecanoic acid) as a function
of temperature. As it shown by the spectra, the fraction of 5cHS in the mutant is much more
accentuated in the mutant compared to wild-type. Figure 4.5C and D show the van’t Hoff
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plot generated from the equilibrium constant determined from these spectra. Table 4.3
compiles all of the thermodynamic parameters derived from these plots of the enzyme with
eicosanoic acid (a long-chain fatty acid and native substrate), dodecanoic acid and the
substrate-free enzyme.
Enthalpy values indicate that the 6cLS to 5cHS transition is endothermic as observed in
the UV-Vis spectra. Theoretical investigation from the entropic changes between low-spin
and high-spin in other heme-containing proteins determined the ΔS associated with this
transition to be ~2 cal/mol K.35 In OleTSA these changes are significantly larger, suggesting
the involvement of a protein or substrate conformational change in addition to the
electronic rearrangement. The entropy change originating from a substrate conformational
change should be identical in both wild-type and mutant as the nature of the substrate is
the same. In the case of a structural rearrangement that derives from the protein itself, the
ΔS should be highly similar, if not identical, as it is very unlikely the alanine to proline
mutation induces a major alteration in protein structure. If the heme properties have been
altered however, the difference in ΔS values between WT and mutant should be evident
but modest and should be in the same order of magnitude as to what has been postulated to
be the ΔS of the pure electronic spin transition in other ferrihemoproteins (2 cal/mol K).35
In the substrate-free form the difference between ΔS in the WT and mutant enzyme is ~3
cal/mol K. This small difference suggests a change of the heme electronic structure has
occurred Similar values are obtained with dodecanoic acid, following the same trend of a
subtle increase in the entropy change. In the case of the eicosanoic acid-bound A369P
however, the entropy change is two-fold higher than in wild-type and much more
significant than in the substrate-free or dodecanoic acid-bound enzymes. We have
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previously shown that long-chain substrates induce protein conformational changes in
OleTJE as the protein needs to accommodate its pocket for binding of the substrate.13 The
fact that the entropy change with eicosanoic acid is much higher would be expected
however, the large shift of the ΔS in the mutant is rather surprising as it would indicate that
the mutation affects this conformational change. A possible explanation would be that this
major shift in protein structure might accentuate the observed change in the heme electronic
structure in the substrate-free form by inducing a variation of the geometry of the heme.
Although this data clearly demonstrates a change in the ΔS of the spin transition, it would
be naïve to assign this difference to a single parameter. In any case, Kspin values appear to
be at least an order of magnitude higher in all forms of the A369P mutant compared to
wild-type, conclusively showing that this mutation alters the spin-state equilibrium to favor
the high-spin state of the protein. Further examination of these changes is necessary to
uncover where this spin transition is originating from. Possibilities of this alteration might
include a change in the Fe-S bond strength, a change in the geometry of the heme or more
major protein conformational rearrangements. These possibilities are discussed below.

3.4 OleTSA_A369P has an apolar cavity and an altered heme geometry
Magnetic circular dichroism (MCD) and electron paramagnetic resonance (EPR)
are highly informative techniques in cytochrome P450 spectroscopy providing specific
fingerprints of defined heme environments, including ligands, polarity and geometry of the
heme.21 Andersson et al demonstrated that when the carbonmonoxy ferrous form of P450s
with a well-hydrated pocket (like P450terp) is analyzed by MCD spectroscopy, it tends to
absorb at higher wavelengths compared to P450s with more hydrophobic cavities (such as
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that for P450cam).36 Given the hydrophobic nature of the binding pocket in OleTSA, it is
expected that the cavity would be more dehydrated compared to other P450s. Figure 4.6A,
black line, shows that the carbon-monoxy ferrous form of the substrate-free OleTSA
enzyme has a positive absorbance at 441 nm, this is similar to the value found in P450cam
which has a maximal absorbance at 443 nm,36 supporting a non-polar pocket. Since the
spin shift in P450s involves the loss of a water ligand from the Fe(III) center, the A369P
mutant which has a higher propensity to be in the 5cHS state should have a less polar
pocket than the wild-type OleTSA. MCD spectra of the carbon-monoxy ferrous form of the
enzymes showed very minimal changes (roughly 1 nm) between the WT and A369P
mutant, suggesting that the hydration of the pocket might be retained. Although the A369P
mutant favors the 5cHS state, the solvent molecule might not be completely absent, which
would explain the relatively unperturbed MCD spectra.

Figure 4.6 MCD spectra of OleTSA wild-type and A369P. (A) MCD spectra of the carbonmonoxy ferrous forms. Black trace represents wild-type, red trace represents A369P. (B)
MCD spectra of the ferric forms of OleT SA. Black solid line represents wild-type substratefree; red solid line represents A369P substrate-free; black dashed line represents wild-type
bound to C20 fatty acid; red dashed line represents A369P bound to C20 fatty acid.
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Figure 4.6B shows the MCD spectrum of the ferric forms of the enzyme in the absence and
presence of eicosanoic acid. In all cases, the spectrum of the A369P mutant is red-shifted
by 1.5 nm. Given the fact that MCD spectroscopy is unaffected by changes in the protein
conformation unless they affect the heme, it can be speculated that the prosthetic group of
the A369P mutant has a different conformation. The same phenomenon has been observed
in other ferrihemoproteins such as cytochrome c.37 Further MCD using near-IR
absorbances is necessary as there are distinct S (ℼ) → Fe charge transfer contributions in
that region that could give information on the strength of the Fe-S bond.38-39
EPR spectra of both proteins in the substrate-free and substrate-bound form shows
significant changes in the S = 5/2 signal. Figure 4.7 shows the EPR spectrum of OleT SA
and the A369P mutant. The black trace corresponds to the substrate-free and the red trace
to the eicosanoic acid bound form.

Figure 4.7 EPR spectra of OleTSA wild-type and A369P mutant. (A) EPR spectrum of
OleTSA wild-type. The black trace represents the substrate-free form of the enzyme and red
trace the eicosanoic acid bound form. (B) EPR spectrum of OleT SA A369P. Black trace
represents the substrate-free form and red trace the eicosanoic acid bound form.
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Initial examination of the EPR spectrum of the A369P mutant reveals the presence of a
high fraction of a rhombic signal typical of a S = 5/2 (5cHS) with g values of 7.87, 3.69
and 1.76 for the substrate-free form and 7.72, 3.77 and 1.73 for the C20 bound respectively.
In the absence of substrate, the former is substantially higher than in wild-type, which
displays a rhombic signal typical of a spin system with S = 1/2 (6cLS). The low spin signal
of the EPR spectrum of the A369P mutant displays a similar trend as the wild-type with
multiple gz values, which suggest a highly disordered water network on the distal side of
the heme. When substrate is added, the S = 5/2 signal corresponding to the 5cHS state is
decreased in the A369P mutant. This is conflicting as to what is often expected since the
substrate should drive the protein to the 5cHS state. In fact, it appears that the addition of
substrate highly structures the hydrogen bond network of the distal side of the heme as only
2 gz values are now evident in the S = ½ signal.
The most important factor that can be derived from this data however, is the fact that the
rhombicity of the S = 5/2 signal of the C20-bound OleTSA_A369P enzyme is substantially
decreased compared to the wild-type. This type of change has been seen in the F429H
mutation in CYP2B4. Davydov R et al.40 demonstrated that this mutation decreases the
rhombicity of the S = 5/2 EPR signal. Although this change might be due to a change in
the H-bonding network of the proximal side of the heme in OleTSA, it can also originate
from a change in the heme geometry. In addition to this, the rhombicity of the substratefree form is higher than with substrate bound, suggesting that the long-chain fatty acid
distorts the heme. This supports the idea discussed in the previous section that the
conformational change induced by C20 fatty acid might accentuate the change of the
electronic structure of the heme. The data so far suggests that the largest structural changes
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derive from alterations in heme geometry rather than changes in the H-bonding network of
the proximal side of the protein. Higher resolution spectroscopy is necessary to elucidate
these phenomena.

3.5 Resonance Raman indicates a change in the vinyl orientation of the heme
in the A369P mutant

One of the most sensitive techniques for P450s is resonance Raman spectroscopy.
Information about the spin-state of the heme, as well as oxidation state of the Fe center and
geometry of the heme can be derived with this technique. 21 Moreover, the relative strength
of the Fe-S bond can be derived from the analysis of the carbon-monoxy ferrous form of
P450s which would conclusively say whether the strength of the bond has changed. Figure
4.8 shows the high-frequency region of the wild-type and A369P enzymes in the presence
of C20 and C12 fatty acids. The oxidation marker at 1374 cm-1 indicate that all samples are
in the ferric state as expected. Spin-state markers of the 5cHS form at 1489 cm-1 , 1565 cm1

and 1626 cm-1 indicate that the A369P mutant (Figure 4.8B) contains substantially more

5cHS heme than the wild-type, even in the substrate free form. The accumulations of the
5cHS state were determined by employing the derived resonance Raman scattering crosssection of the 1489 cm-1 spin state marker of P450cam, using the ratio of I HS/LS = 1.24.41
These values seem to be in accordance to what was determined in the optical spectroscopy
studies at low temperature.

155

Figure 4.8 High-frequency region of the resonance Raman spectra of OleTSA and
OleTSA_A369P. (A) OleTSA wild-type. (B) OleTSA_A369P. Oxidation marker at 1374 cm1
is represented in scarlet. Spin state marker of the 5cHS form at 1489 cm-1, 1563 cm-1 and
1626 cm-1 is presented in orange. Spin state marker of the 6cLS form at 1503 cm-1, 1581
cm-1 and 1635 cm-1 are marked in red.

Figure 4.9 shows the low-frequency region of the resonance Raman scattering for the wildtype and A369P enzyme in the presence of eicosanoic acid. Interestingly, the porphyrin
out-of-plane modes occurring at 307 cm-1, 332 cm-1, 496 cm-1, 695 cm-1 and 713 cm-1
indicate a highly distorted heme cofactor. A similar pattern is seen both with C12 fatty acid
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bound and the substrate-free form. The most pronounced change, however, is seen between
400 – 440 cm-1 , a region that corresponding to the vinyl bending modes.

Figure 4.9 Resonance Raman scattering of the low-frequency region of OleTSA and
OleTSA_A369P. Bending mode corresponding to a planar vinyl orientation is highlighted
in cyan at 414 cm-1. Bending mode corresponding to an out-of-plane vinyl orientation is
highlighted in green at 428 cm-1.

The resonance Raman spectrum shows the wild-type enzyme having a higher intensity at
428 cm-1 relative to 414 cm-1. Based on assignments from myoglobin and other P450s, 42
the latter correlates to a planar orientation of the vinyl groups of the heme, whereas the
former corresponds to a more out-of-plane orientation, indicating that the wild-type favors
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a planar orientation of the vinyl modes. In the A369P mutant, this tendency is reversed,
favoring the out-of-plane orientation. This conclusively indicates that the geometry of the
heme is affected in the A369P mutant by changing the orientation of the vinyl modes.
As previously mentioned, one of the most important factors that can be determined
using resonance Raman is the strength of the Fe-S bond of the heme. Scattering of the
carbon-monoxy ferrous adducts can help determine the strength of this bond by measuring
the changes of the internal modes of the Fe-CO fragment which depend on the extent of
the dℼ (Fe) to CO (ℼ*) backbonding donation.43 Figure 4.10 and 11 show the low- and
high-frequency resonance Raman spectra respectively of the carbon-monoxy adducts in
the presence and absence of fatty acids. In the substrate-free wild-type enzyme, a single
Fe-CO fragment can be detected with the ν(Fe-C) frequency observed at 478 cm-1 and the
corresponding ν(C-O) mode observed at the higher frequency of 1943 cm-1. The A369P
mutant exhibits a change in the Raman shift to 482 cm-1 in the low-frequency region and
to 1938 cm-1 in the high-frequency region, suggesting a change in the Fe-CO bond. Binding
of C12 fatty acid to the wild-type enzyme gives rise to two distinct frequencies at 477 and
489 cm-1 whereas the mutant gives rise to only one at 486 cm-1, indicating that C12 fatty
acid most likely interacts with the CO adduct allowing two conformations in the wild-type
and only one in the A369P mutant.44 This effect is reversed with C20 fatty acid where the
mutant exhibits two conformers whereas the wild-type only one, suggesting that the
conformation of the fatty acid is highly flexible in the active site and is chain length
dependent. Such dependence however, appears to have changed in the A369P mutant. A
reasonable explanation for this could be the change in heme geometry and could explain
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the effects observed with the thermodynamic data where large differences in the ΔS
between the WT and A369P can be observed with C20 fatty acid but not with C12.

Figure 4.10 Low-frequency region of the resonance Raman spectra of the carbon-monoxy
ferrous adducts of OleTSA and OleTSA_A369P
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Figure 4.11 High-frequency region of the resonance Raman spectra of the carbon-monoxy
ferrous adducts of OleTSA and OleTSA_A369P
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Further examination of the H-bonding network to the Fe-S bond can be derived by plotting
the inverse backbonding correlation line between the ν(Fe-C) and ν(CO) frequencies as
shown in Figure 4.12.

Figure 4.12 CO backbonding correlation line. Yellow squares correspond to data points
for nitric oxide synthase (NOS), grey circles correspond to data points for P450cam; blue
triangles correspond to OleT SA; orange squares correspond to OleT SA_A369P

It has been established that P450cam possesses a stronger donor thiolate ligand compared
to nitric oxide synthase (NOS) enzymes.43-44 The change in strength arises from the fact
that a tryptophan residue on the cys-pocket of NOS enzymes is hydrogen bonded to the
proximal cysteine sulfur, thus weakening the Fe-S bond.45-46 In the CO backbonding
correlation, line this manifests in P450cam having a line well below that of NOS. In
OleTSA, this line is comparable to P450cam indicating that the strength of the thiolate
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ligand donation is comparable and significantly stronger than NOS. The A369P mutant
follows a very similar correlation to the wild-type enzyme, suggesting that there is no
significant change in the electronic properties of the thiolate ligand. This indicates that if
there is a change in the H-bonding network of the cys-pocket of the mutant, it may only
have minimal effects in the strength of the Fe-S bond.
Summarizing the resonance Raman data, it can be concluded that the A369P mutation does
not significantly affect the hydrogen bonding network of the Fe-S bond as previously
anticipated. Rather, the larger effects are comprised of changes in the heme geometry that
in turn cause changes to Kspin. It is important, however, to directly examine the ν(Fe-S)
modes as this would give a more definitive answer on whether the Fe-S bond has been
changed.

3.6 Crystal structure of OleTSA A369P shows a change in heme geometry
To further investigate the changes in heme properties, we determined the crystal
structure of the OleT SA A369P mutant at a resolution of 2.3 Å. The data statistics for the
crystal structure can be found on table 4.4. The crystal structure of OleT SA wild-type is the
same as the one discussed in chapter 3 as well as the statistics corresponding to that
structure. Similar conditions were used to crystallize the A369P mutant. The only
difference was the use of a higher protein concentration in the crystallization tray. The
concentration was increased to 30 mg/mL, twice the amount used for the wild-type.
Crystals obtained were significantly larger than in wild-type and were singular.
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Table 4.4 Data collection and structure refinement statistics of OleT SA A369P
Data Collection
Statistics

OleTSA_A369P C20bound

Resolution Range (Å)

35.57 - 2.3

Space group
Unit cell (a/b/c; Å)
(α/β/γ; °)
Total reflections
Unique reflections
Multiplicity
Completeness
Mean I/sigma (I)
Wilson B-factor (Å2)
Rmerge
Rmeas
Rpim
CC1/2
CC

C2221
68.7 94.9 185.1
90 90 90
210112 (19367)
27174 (2687)
7.7 (7.2)
99.5 (99.9)
8.7 (1.5)
32.4
0.144 (0.922)
0.154 (0.994)
0.05462 (0.3658)
0.997 (0.771)
0.999 (0.933)

Structure Refinement
Statistics

OleTSA_A369P C20bound

Reflections used in
refinement
Reflections used for Rfree
R-work
R-free
Number of nonhydrogen atoms
Macromolecules
Ligands
Protein residues
RMS (Bonds; Å)
RMS (Angles; °)
Ramachandran favored
(%)
Ramachandran allowed
(%)
Ramachandran outliers
(%)
Rotamer outliers (%)
Clashscore
Average B-factor (Å2)
Macromolecules
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27169 (2686)
1058 (104)
0.2191 (0.2932)
0.2386 (0.3043)
3669
3411
65
419
0.011
1.2
96.16
3.84
0
0
12.75
36.22
36.35

The crystal structure of the A369P mutant reveals the conservation of all the secondary
structural elements of the protein. No significant changes can be seen in the region directly
below the heme where the residue 369 sits. This is unsurprising as the alanine to proline
mutation is not very stringent as demonstrated by its presence in other CYP152 enzymes.
Preliminary analysis of the active site of the protein, showed that the electron density of
the heme cofactor is more concave compared to the wild-type (Figure 4.13).

Figure 4.13 2FO-FC map of the heme in (A) OleTSA_A369P and (B) OleTSA wild-type. The
contour level is set at 1.6 σ.

The change in heme planarity was further examined by measuring the torsion angle
between one of the vinyl groups, the Fe center and the methyl group opposite to the vinyl
group. Figure 4.14 A and B show the angle change between the wild type and the mutant
enzyme. The A369P variant shows an angle of 154.2° compared to the 169.7° shown in
the WT. The difference in torsion angles confirms the distortion of the heme to a more
saddled configuration. These geometric properties can be analyzed in more detail by using
the Normal-Coordinate Structural Decomposition (NSD) software developed by
Shelnutt.27 By entering the coordinates of the crystal structure, this program gives
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Figure 4.14 Crystal structure of the active site of OleT SA and the A369P mutant. (A)
OleTSA wild-type showing the distortion angle. (B) OleTSA A369P showing the distortion
angle. (C) OleTSA wild-type showing the change in the H-bonding network to the Fe-S
bond. dH1-S = 2.8 Å; θN-H1-S = 142°; dH2-S = 3 Å; θN-H2-S = 121°; dH3-S = 3.4 Å; θN-H3-S = 83°
(D) OleTSA A369P showing the change in the H-bonding network to the Fe-S bond. d H1-S
= 2.7 Å; θN-H1-S = 150°; dH2-S = 2.5 Å; θN-H2-S = 141°.
quantitative information about the out-of-plane distortion (Doop) and which heme
conformation is favored in the heme (saddled, planar, propeller, ruffled etc). Analysis of
the crystal structure of both protein variants indicated an out-of-plane distortion of 1 Å
versus 0.8 Å in the wild-type enzyme. This is a significant change as seen in other hemecontaining proteins 47 and indeed large enough to alter the electronic properties of the heme.
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Additionally, these results indicate that the heme in the A369P mutant favors more a
saddled conformation compared to the wild-type where a ruffled conformation is more
prevalent. Analysis of the hydrogen bonding network of the cys-pocket of the wild-type
enzyme shows three residues within H-bonding distance of the Fe-S bond. H1 represented
in Figure 4.14C 1 originates from the Nε2 atom of Gln357 with a distance of 2.8 Å and a
N-H-S angle of 142°; H2 originates from the amide hydrogen of Gly370 at a distance of 3
Å to the S atom and an angle of 121°. The last bond (H3) originates from the amide
hydrogen of Ala369 and is 3.4 Å from the thiolate ligand with an angle of 83°; this is in
the limit of hydrogen bonding distance, suggesting that this residue might not play a
significant role in reactivity. In the A369P mutant, H3 is missing due to the elimination of
the hydrogen from the amide of the proline residue. H1 seems to be mostly unaffected as
the distance is 2.7 Å and the angle 150°; H2 however, seems to be have been placed 0.5 Å
closer to the Fe-S bond with a steeper angle of 141°.
The crystal structure of the OleTSA A369P mutant shows a clear disruption in the geometric
conformation of the heme. This data correlates well with results derived from resonance
Raman, MCD and EPR spectroscopies. It is also clear that the A369P mutant has a
disrupted hydrogen bonding network in the proximal side of the heme. However, this
change is not evident in any of the spectroscopies performed thus far. More in-depth
analysis of the Fe-S bond must be done in order to clarify the effects of this change on the
donation properties of the thiolate ligand.
Although we have changed the Kspin of the heme by altering its geometry, it is necessary to
correlate these changes to the reactivity of the protein as it would be expected that these
alterations would affect the redox potential of the heme.
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3.7 The change in heme geometry in OleTSA A369P allows for the
stoichiometric preparation of compound I
The main goal of this study has been to modify the protein to obtain large amounts
of the catalytically relevant intermediates in OleT SA to allow their electronic
characterization using high resolution spectroscopy. A mutation in the residue adjacent to
the functional cysteine of the protein from an alanine residue to a bulkier proline induces
an alteration in the spin-state equilibrium of the enzyme favoring the 5cHS state of the
heme. This alteration can be attributed to a change in the geometry and conformation of
the heme as indicated by the crystal structure and resonance Raman analysis. Previous
studies on other heme-containing enzymes have shown that the heme conformation is very
important in the reactivity of the protein.47 This is unsurprising as P450s naturally change
the conformation of their heme upon substrate binding. This change in conformation allows
them to decrease their redox potential to allow electron transfer from their natural redox
partner.48-49 In addition to this, previous literature has shown that changes in heme
conformation can affect the affinity for small molecules like O 2, CN- and NO thus changing
the reactivity of the protein.47, 50 From all this, it can be speculated that the mutation in
OleTSA would have an effect in the overall reactivity of the protein. In accordance to what
has been published, it is possible that the more saddled conformation of the heme would
decrease the affinity of the protein for hydrogen peroxide. It is also possible that the
catalytically relevant intermediates to have different reactivities. To clarify these
suppositions, we performed stopped-flow spectroscopy with OleTSA A369P in the presence
of protiated eicosanoic acid (h39-C20) or deuterated eicosanoic acid (d 39-C20). All the
conditions are identical to what was previously described in chapter 3 with the wild-type
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enzyme. Briefly, 20 µM of protein-substrate complex were rapidly mixed with 10 mM
hydrogen peroxide and the spectrum was monitored using a photodiode array (PDA) for
the full spectrum or a photomultiplier tube (PMT) for single wavelength traces.
Initial look at the PDA spectra obtained from the reaction of d39-C20 bound OleTSA
mutant and excess H2O2 (Figure 4.15A) reveals the almost stoichiometric accumulation of
the compound I species as determined by singular value decomposition analysis. This is a
25 % increase to what is observed with the wild-type enzyme. Moreover, no compound II
accumulation can be observed in either variant of the protein. As discussed in the previous
chapter, the lack of compound II accumulation can be explained by the higher decay rate
of the compound II species compared to the initial compound I species in the wild-type
enzyme. It would appear that this same effect is observed in the mutant.

Figure 4.15 Photodiode array spectra of 10 µM OleTSA A369P-substrate complex rapidly
mixed with 5 mM hydrogen peroxide. (A) PDA spectra of OleT SA A369P bound to
perdeuterated eicosanoic acid. (B) PDA spectra of OleT SA A369P bound to protiated
eicosanoic acid. Initial trace is shown in black; final trace is shown in red; SVD analysis
of the pure compound I species is shown in dashed blue.
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Analysis of the h39-C20 reaction indicates a similar trend in the accumulation of compound
I with the A369P mutant accumulating 70% compared to the 50% observed in the wildtype enzyme. Further evaluation of the spectra reveals the accumulation of 80 % of the
compound II intermediate compared to the 50 % in the wild-type enzyme under similar
conditions. The higher accumulation of compound II with protiated substrate is expected
as the decay rate of compound I is largely increased due to the kinetic isotope effect.
Overall it appears that the A369P mutant is able to accumulate substantially higher
concentrations of both intermediates compared to wild-type. As we previously discussed,
we anticipate that the higher accumulation is caused by the shift in the Kspin of the heme
favoring more the 5cHS state. To determine the decay rates of both intermediates, we
monitored the single wavelength traces at 690 nm (cpd I) and at 440 nm (cpd II) as
described in the previous chapter. Figure 4.16 shows the representative traces of both
protiated and perdeuterated substrate bound OleTSA_A369P. The final rates and
accumulations are summarized in table 4.5.
Table 4.5 Accumulation and decay rates of transient intermediates of OleT SA and OleTSA
A369P.
d39-C20
WT
A369P
Compound
I

Compound
II

h39-C20
WT
A369P

Max
Accumulation
(%)

65

95

40

70

Decay Rate
(s-1)

38

19

513

368

Max
Accumulation
(%)

-

-

50

80

Decay Rate
(s-1)

-

-

53

19
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5cHS at 4
C

Max
Accumulation
(%)

75

95

75

95

Figure 4.16 Representative traces of the absorbance at 690 nm (compound I) and 440 nm
(compound II). (A) Single wavelength trace at 690 nm of OleT SA A369P perdeuterated acid
bound. (B) Single wavelength trace at 690 nm of OleT SA perdeuterated acid bound. (C)
Single wavelength trace at 690 nm of OleTSA A369P protiated acid bound. (D) Single
wavelength trace at 690 nm of OleT SA protiated acid bound.
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As described in table 4.5, the decay rate of both intermediates seems to have changed in
the A369P mutant. In the case of the compound I intermediate, a two-fold lower decay rate
can be observed with perdeuterated substrate in the A369P mutant. A similar decrease is
observed with the protiated substrate. The change in the decay rates appears to be subtle
but confirms that the A369P mutant has a slightly less reactive compound I species. The
observed kinetic isotope effect (kH/kD) also appears to be altered as it was determined to
be 19 for the A369P mutant compared to 13 in the wild-type enzyme. A more substantial
effect can be observed in the decay rates of compound II as the A369P mutant also shows
a 2.5-fold less reactive intermediate.
Although the stability of compound I and II appears to have changed in the mutant, they
are still within the same order of magnitude as in the wild-type enzyme. The increased
stability of the intermediates could in principle serve to promote an increase of
decarboxylation activity as compound II would have a higher chance to perform PCET step
with the substrate radical. This needs to be confirmed by multiple turnover assays and is
currently a work in progress.
To examine the effects of the alteration in heme geometry on the affinity of hydrogen
peroxide for the enzyme, we plotted the formation rates of compound I with the deuterated
eicosanoic acid bound enzymes as a concentration of hydrogen peroxide. Figure 4.17
indicates that the wild-type enzyme can activate hydrogen peroxide better than the mutant
as revealed by the steeper slope. This goes in accordance to what is seen in other
ferrihemoproteins where a saddled conformation of the heme leads to a decrease in affinity
for O2 binding.50 A possible explanation for this is that the more concave form of the
porphyrin hampers the initial binding of hydrogen peroxide.
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Figure 4.17 Hydrogen peroxide activation in OleTSA. Black trace represents the wild-type
enzyme and the red trace represents the A369P mutant.

All the data shown so far indicates that the mutated form of the enzyme can accumulate
the catalytically relevant intermediates better than the wild-type form. The enhanced
accumulation of these intermediates can be partially explained by their increased
stabilization as the decay rates appear to be lower in the A369P mutant however, this does
not fully account for the high disparity in the accumulation of compound I and compound
II. A second parameter that could explain this phenomenon is a better affinity for hydrogen
peroxide. As we previously discussed, this is not the case as the hydrogen peroxide
activation of the A369P is decreased and should lead to a lower accumulation of compound
I. It is rational to attribute the change in accumulation to the change in the spin equilibrium
of the protein which highly favors the 5cHS state.
The capture of the transient intermediates in OleT SA using rapid freeze-quench is necessary
for their study using advanced spectroscopy. Usually, the “dead-time” of this instrument
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tends to be in the order of 10 milliseconds. In other words, maximal accumulation of the
intermediate is necessary at 10 ms to avoid any mixture of the species. Figure 4.18 shows
the speciation plots of the wild type and the A369P mutant as a function of time. Figure
4.18A and B clearly demonstrates that the A369P mutant with perdeuterated eicosanoic
acid is more suited for the capture of the compound I intermediate, as it shows that at 10

Figure 4.18 Speciation plots of OleT SA wild-type and A369P. (A) Speciation plot of the
A369P mutant with deuterated eicosanoic acid. (B) Speciation plot of the wild-type enzyme
with perdeuterated eicosanoic acid. (C) Speciation plot of the A369P mutant with protiated
eicosanoic acid. (D) Speciation plot of the wild-type enzyme with protiated eicosanoic
acid. Green traces correspond to compound I; Orange traces correspond to compound II;
red traces correspond to the 6cLS.
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ms 80 % of the protein is in the compound I state compared to only 57% in the wild-type
enzyme. This can also be described for the compound II intermediate with protiated
eicosanoic acid. Figure 4.18C and D describe the fraction of each intermediate as a function
of time and indicates that at 10 ms 75% of the protein is in the compound II state compared
to only 49% in the wild-type enzyme. The speciation plots conclusively indicate that the
intermediates in OleTSA A369P are suitable for their capture using rapid freeze-quench.
In addition to the required accumulation of the species, high protein concentrations are also
necessary to capture these intermediates for their EPR and Mössbauer analysis. In chapter
3 we approached this problem by describing the improved stability of OleT SA at high
concentration compared to the highly studied OleT JE. Figure 4.19 shows the PDA trace of
OleTSA and the mutant in the presence of perdeuterated eicosanoic acid. This trace reveals
the stoichiometric accumulation of compound I even at a concentration of 100 µM postmix and conclusively shows that the protein is now well suited for high resolution
spectroscopy.

Figure 4.19 High concentration stopped-flow of OleTSA. (A) OleTSA wild-type 100 µM
post-mix bound to perdeuterated eicosanoic acid. (B) OleT SA A369P 100 µM post-mix
bound to perdeuterated eicosanoic acid. The intensity of the absorbance of compound I
(690 nm) is accentuated in A369P.
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4. Conclusion
Decarboxylases from the CYP152 family of P450s are fascinating enzymes. Their
ability to catalyze multiple chemistries on single substrates is remarkable. The
biotechnological potential of these enzymes however, rely on their ability to completely
funnel their chemistry into the decarboxylation process to produce suitable amounts of
terminal olefins and only small amount of (undesirable) hydroxylated side-products.
Although much progress has been made to understand the origin of this chemistry
multiplicity, there is still many properties of the proteins that need to be deciphered.
Although we have previously shown the importance of substrate positioning and protein
conformational rearrangements on the decarboxylation process, we are still unable to
understand how this protein is able to stabilize its catalytically relevant intermediates
compound I and II. To this day, the ability to study the electronic properties of these
intermediates has been hampered by the demanding conditions of the rapid-freeze quench
process: high protein and substrate concentration. We approached the former in the
previous chapter by identifying a more stable decarboxylase. In this chapter, we addressed
the latter by altering the Kspin of OleT SA to favor the 5cHS accumulation. A change from
an alanine to a proline induces a change in the geometry of the heme to a more saddled
conformation, which, at its turn, is translated to a change in the spin-state of the protein
allowing higher accumulation of the transient intermediates of OleT SA. This study
ultimately establishes a new platform for the study of the electronic properties of the ferryl
species in decarboxylases of this family. Ongoing experiments include redox potential
studies, activity assays and EPR/Mössbauer studies of the transient species. Further
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examination of the effects of this mutation will provide a better understanding of the effects
of heme conformation in P450s.
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